# EDGAR Filing Document

**Accession Number:** 0001841440
**File Stem:** 0001193125-26-031055
**Filing Date:** 2026-1
**Character Count:** 141000
**Document Hash:** 182614ad81f92671302df5eb5d25be92
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-031055.hdr.sgml**: 20260130

**ACCESSION NUMBER**: 0001193125-26-031055

**CONFORMED SUBMISSION TYPE**: N-CSRS

**PUBLIC DOCUMENT COUNT**: 17

**CONFORMED PERIOD OF REPORT**: 20251130

**FILED AS OF DATE**: 20260130

**DATE AS OF CHANGE**: 20260130

**EFFECTIVENESS DATE**: 20260130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Capital Group Central Fund Series II
- **CENTRAL INDEX KEY:** 0001841440

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** N-CSRS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23633
- **FILM NUMBER:** 26581408

**BUSINESS ADDRESS:**
- **STREET 1:** 6455 IRVINE CENTER DRIVE
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92618
- **BUSINESS PHONE:** (213) 486-9200

**MAIL ADDRESS:**
- **STREET 1:** 333 SOUTH HOPE STREET, 55TH FLOOR
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90071

## Series and Classes Contracts Data

### Capital Group Central Corporate Bond Fund (Series ID: S000071511)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000226800 | Class M      | CCBFX           |

?xml version='1.0' encoding='ASCII'? 0cb8e979-5939-4e8d-a773-b15fa4c0f741

#### UNITED STATES

#### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

#### FORM N-CSR

------

#### CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES

#### Investment Company Act file number
811-23633

#### Capital Group Central Fund Series II
(Exact name of registrant as specified in charter)

------

6455 Irvine Center Drive

Irvine, California 92618

(Address of principal executive offices)

Becky L. Park

6455 Irvine Center Drive

Irvine, California 92618

(Name and address of agent for service)

#### Registrant's telephone number, including area code:
&nbsp;&nbsp;&nbsp;&nbsp;(949) 975-5000

#### Date of fiscal year end:
May 31

#### Date of reporting period:
November 30, 2025

ITEM 1 - Reports to Stockholders

![TSR - American Funds Logo](images_2355.jpg)

SEMI-ANNUAL SHAREHOLDER REPORT

## Capital Group Central Corporate Bond Fund
**Class M \| CCBFX** for the six months ended November 30, 2025

This semi-annual shareholder report contains important information about Capital Group Central Corporate Bond Fund (the "fund") for the period from June 1, 2025 to November 30, 2025. You can find additional information about the fund at

capitalgroup.com/CCBF-M. You can also request this information by contacting us at (800) 421-4225.

**What were the fund costs for the last six months?** (based on a hypothetical $10,000 investment)

---

| |
|:---|
| &nbsp;&nbsp;**Share class** |
| &nbsp;&nbsp;Class M&nbsp;&nbsp;$0<sup>1</sup>0.00%<sup>2,3</sup> |

---

<sup>1</sup> Amount less than $1.

<sup>2</sup> Amount less than 0.01%

<sup>3</sup> Annualized.

Key fund statistics

---

| | |
|:---|:---|
| Fund net assets (in millions) | $11094 |
| Total number of portfolio holdings | 791 |
| Portfolio turnover rate | 105% |

---

**Portfolio holdings by sector** (percent of net assets)

\*Includes derivatives.

Availability of additional information

Additional information about the fund, including its prospectus, financial information, holdings, and proxy voting information is available at

capitalgroup.com/CCBF-M.

#### Important information
To reduce fund expenses, only one copy of most shareholder documents will be mailed to shareholders with multiple accounts at the same address (householding). If you would prefer that your documents not be householded, please contact Capital Group at (800) 421-4225, or contact your financial intermediary. Your instructions will typically be effective within 30 days of receipt by Capital Group or your financial intermediary.

Lit. No. MFMXSRX-137-0126© 2026 Capital Group. All rights reserved.

------

#### ITEM 2 - Code of Ethics
Not applicable for filing of semi-annual reports to shareholders.

------

#### ITEM 3 - Audit Committee Financial Expert
Not applicable for filing of semi-annual reports to shareholders.

------

#### ITEM 4 - Principal Accountant Fees and Services
Not applicable for filing of semi-annual reports to shareholders.

------

#### ITEM 5 - Audit Committee of Listed Registrants
Not applicable to this Registrant, insofar as the Registrant is not a listed issuer as defined in Rule 10A-3 under the Securities Exchange Act of 1934.

------

#### ITEM 6 - Investments
The schedule of investments is included as part of the material filed under Item 7 of this Form.

------

#### ITEM 7 - Financial Statements and Financial Highlights for Open-End Management Investment Companies

------

![](imgcdbf9cc51.jpg)

**Capital Group Central Corporate Bond Fund**

Financial Statements and Other Information

N-CSR Items 7-11

for the six months ended November 30, 2025

Lit. No. MFGEFP2-137-0126© 2026 Capital Group. All rights reserved.

------

Investment portfolio November 30, 2025unaudited

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments 90.24% | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans 82.03%** | **Corporate bonds, notes & loans 82.03%** | **Corporate bonds, notes & loans 82.03%** |
| **Financials 21.85%** | **Financials 21.85%** | **Financials 21.85%** |
| American Express Co. 1.65% 11/4/2026  | USD21,868 | $21425 |
| American Express Co. 2.55% 3/4/2027  | 3270 | 3217 |
| American Express Co. 4.05% 5/3/2029  | 10617 | 10690 |
| American Express Co. 5.284% 7/26/2035 (USD-SOFR + 1.42% on 7/26/2034) <sup>(a)</sup>  | 2746 | 2851 |
| American Express Co. 5.442% 1/30/2036 (USD-SOFR + 1.32% on 1/30/2035) <sup>(a)</sup>  | 21732 | 22736 |
| American International Group, Inc. 4.85% 5/7/2030  | 3000 | 3075 |
| American International Group, Inc. 5.125% 3/27/2033  | 14360 | 14849 |
| American International Group, Inc. 5.45% 5/7/2035  | 15461 | 16222 |
| American International Group, Inc. 4.375% 6/30/2050  | 6292 | 5317 |
| Aon Corp. 5.35% 2/28/2033  | 2129 | 2227 |
| Aon Corp. 3.90% 2/28/2052  | 4071 | 3104 |
| Aon North America, Inc. 5.45% 3/1/2034  | 33892 | 35463 |
| Aon North America, Inc. 5.75% 3/1/2054  | 14191 | 14403 |
| Arthur J. Gallagher & Co. 5.00% 2/15/2032  | 2015 | 2065 |
| Arthur J. Gallagher & Co. 5.15% 2/15/2035  | 40468 | 41113 |
| Arthur J. Gallagher & Co. 3.50% 5/20/2051  | 863 | 617 |
| Arthur J. Gallagher & Co. 5.55% 2/15/2055  | 3719 | 3624 |
| Athene Global Funding 5.543% 8/22/2035 <sup>(b)</sup>  | 3000 | 3021 |
| Athene Holding, Ltd. 6.625% 5/19/2055  | 21180 | 21987 |
| Bank of America Corp. 5.162% 1/24/2031 (USD-SOFR + 1.00% on 1/24/2030) <sup>(a)</sup>  | 8300 | 8612 |
| Bank of America Corp. 1.898% 7/23/2031 (USD-SOFR + 1.53% on 7/23/2030) <sup>(a)</sup>  | 10596 | 9555 |
| Bank of America Corp. 1.922% 10/24/2031 (USD-SOFR + 1.37% on 10/24/2030) <sup>(a)</sup>  | 45116 | 40476 |
| Bank of America Corp. 2.299% 7/21/2032 (USD-SOFR + 1.22% on 7/21/2031) <sup>(a)</sup>  | 57805 | 51867 |
| Bank of America Corp. 5.872% 9/15/2034 (USD-SOFR + 1.84% on 9/15/2033) <sup>(a)</sup>  | 1372 | 1479 |
| Bank of America Corp. 5.468% 1/23/2035 (3-month USD CME Term SOFR + 1.65% on 1/23/2034) <sup>(a)</sup>  | 10610 | 11163 |
| Bank of America Corp. 2.831% 10/24/2051 (USD-SOFR + 1.88% on 10/24/2050) <sup>(a)</sup>  | 7017 | 4601 |
| Bank of America Corp. 2.972% 7/21/2052 (USD-SOFR + 1.56% on 7/21/2051) <sup>(a)</sup>  | 410 | 276 |
| Bank of New York Mellon Corp. 5.802% 10/25/2028 (USD-SOFR + 1.802% on 10/25/2027) <sup>(a)</sup>  | 11678 | 12078 |
| Bank of New York Mellon Corp. 4.942% 2/11/2031 (USD-SOFR + 0.887% on 2/11/2030) <sup>(a)</sup>  | 29392 | 30292 |
| Bank of New York Mellon Corp. 5.225% 11/20/2035 (USD-SOFR + 1.253% on 11/20/2034) <sup>(a)</sup>  | 6236 | 6489 |
| Bank of Nova Scotia (The) 4.75% 2/2/2026  | 17494 | 17506 |
| Berkshire Hathaway Finance Corp. 4.20% 8/15/2048  | 10432 | 8912 |
| Berkshire Hathaway Finance Corp. 3.85% 3/15/2052  | 4348 | 3431 |
| Blackstone Reg Finance Co., LLC 4.95% 2/15/2036  | 3650 | 3639 |
| Blackstone, Inc. 5.00% 12/6/2034  | 10655 | 10757 |
| BNP Paribas SA 5.283% 11/19/2030 (USD-SOFR + 1.28% on 11/19/2029) <sup>(a)(b)</sup>  | 5000 | 5153 |
| BPCE SA 6.714% 10/19/2029 (USD-SOFR + 2.27% on 10/19/2028) <sup>(a)(b)</sup>  | 15000 | 15969 |
| BPCE SA 6.293% 1/14/2036 (USD-SOFR + 2.04% on 1/14/2035) <sup>(a)(b)</sup>  | 34350 | 37091 |
| BPCE SA 6.027% 5/28/2036 (USD-SOFR + 1.956% on 5/28/2035) <sup>(a)(b)</sup>  | 11886 | 12627 |
| Brown & Brown, Inc. 4.90% 6/23/2030  | 4000 | 4056 |
| Brown & Brown, Inc. 5.25% 6/23/2032  | 10771 | 11035 |
| Brown & Brown, Inc. 5.55% 6/23/2035  | 17303 | 17797 |
| Brown & Brown, Inc. 6.25% 6/23/2055  | 22924 | 24046 |
| CaixaBank SA 5.673% 3/15/2030 (USD-SOFR + 1.78% on 3/15/2029) <sup>(a)(b)</sup>  | 3504 | 3651 |
| CaixaBank SA 4.885% 7/3/2031 (USD-SOFR + 1.36% on 7/3/2030) <sup>(a)(b)</sup>  | 12300 | 12523 |
| CaixaBank SA 6.84% 9/13/2034 (USD-SOFR + 2.77% on 9/13/2033) <sup>(a)(b)</sup>  | 14800 | 16651 |
| CaixaBank SA 6.037% 6/15/2035 (USD-SOFR + 2.26% on 9/15/2034) <sup>(a)(b)</sup>  | 43046 | 46160 |
| CaixaBank SA 5.581% 7/3/2036 (USD-SOFR + 1.79% on 7/3/2035) <sup>(a)(b)</sup>  | 17944 | 18628 |
| Capital One Financial Corp. 6.377% 6/8/2034 (USD-SOFR + 2.86% on 6/8/2033) <sup>(a)</sup>  | 2371 | 2578 |
| Capital One Financial Corp. 5.884% 7/26/2035 (USD-SOFR + 1.99% on 7/26/2034) <sup>(a)</sup>  | 2359 | 2493 |
| Chubb INA Holdings, LLC 3.35% 5/3/2026  | 8585 | 8562 |
| Chubb INA Holdings, LLC 5.00% 3/15/2034  | 77669 | 79908 |
| Chubb INA Holdings, LLC 4.90% 8/15/2035  | 16193 | 16391 |
| Chubb INA Holdings, LLC 4.35% 11/3/2045  | 400 | 355 |
| Citibank, NA 4.914% 5/29/2030  | 5700 | 5881 |
| Citigroup, Inc. 4.786% 3/4/2029 (USD-SOFR + 0.87% on 3/4/2028) <sup>(a)</sup>  | 16025 | 16254 |
| Citigroup, Inc. 4.542% 9/19/2030 (USD-SOFR + 1.338% on 9/19/2029) <sup>(a)</sup>  | 2941 | 2969 |
| Citigroup, Inc. 2.976% 11/5/2030 (USD-SOFR + 1.422% on 11/5/2029) <sup>(a)</sup>  | 4257 | 4063 |
| Citigroup, Inc. 2.572% 6/3/2031 (USD-SOFR + 2.107% on 6/3/2030) <sup>(a)</sup>  | 21339 | 19803 |
| Citigroup, Inc. 4.503% 9/11/2031 (USD-SOFR + 1.171% on 9/11/2030) <sup>(a)</sup>  | 32740 | 32980 |
| Citigroup, Inc. 2.52% 11/3/2032 (USD-SOFR + 1.177% on 11/3/2031) <sup>(a)</sup>  | 12118 | 10882 |
| Citigroup, Inc. 5.333% 3/27/2036 (USD-SOFR + 1.465% on 3/27/2035) <sup>(a)</sup>  | 13973 | 14425 |

---

---

| | |
|:---|:---|
| **1** | Capital Group Central Corporate Bond Fund |

---

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Financials (continued)** | **Financials (continued)** | **Financials (continued)** |
| Citigroup, Inc. 5.174% 9/11/2036 (USD-SOFR + 1.488% on 9/11/2035) <sup>(a)</sup>  | USD35,288 | $36026 |
| Corebridge Financial, Inc. 3.90% 4/5/2032  | 11777 | 11202 |
| Corebridge Global Funding 4.90% 12/3/2029 <sup>(b)</sup>  | 4525 | 4631 |
| Deutsche Bank AG 2.552% 1/7/2028 (USD-SOFR + 1.318% on 1/7/2027) <sup>(a)</sup>  | 5370 | 5269 |
| Deutsche Bank AG 3.547% 9/18/2031 (USD-SOFR + 3.043% on 9/18/2030) <sup>(a)</sup>  | 2000 | 1907 |
| Deutsche Bank AG 5.403% 9/11/2035 (USD-SOFR + 2.05% on 9/11/2034) <sup>(a)</sup>  | 18713 | 19183 |
| Goldman Sachs Group, Inc. 2.60% 2/7/2030  | 4679 | 4397 |
| Goldman Sachs Group, Inc. 5.049% 7/23/2030 (USD-SOFR + 1.21% on 7/23/2029) <sup>(a)</sup>  | 7365 | 7568 |
| Goldman Sachs Group, Inc. 4.369% 10/21/2031 (USD-SOFR + 1.06% on 10/21/2030) <sup>(a)</sup>  | 44451 | 44513 |
| Goldman Sachs Group, Inc. 1.992% 1/27/2032 (USD-SOFR + 1.09% on 1/27/2031) <sup>(a)</sup>  | 750 | 668 |
| Goldman Sachs Group, Inc. 2.65% 10/21/2032 (USD-SOFR + 1.264% on 10/21/2031) <sup>(a)</sup>  | 12047 | 10920 |
| Goldman Sachs Group, Inc. 5.851% 4/25/2035 (USD-SOFR + 1.552% on 4/25/2034) <sup>(a)</sup>  | 2476 | 2660 |
| Goldman Sachs Group, Inc. 5.536% 1/28/2036 (USD-SOFR + 1.38% on 1/28/2035) <sup>(a)</sup>  | 7078 | 7420 |
| Goldman Sachs Group, Inc. 4.939% 10/21/2036 (USD-SOFR + 1.33% on 10/21/2035) <sup>(a)</sup>  | 57203 | 57438 |
| HSBC Holdings PLC 4.755% 6/9/2028 (USD-SOFR + 2.11% on 6/9/2027) <sup>(a)</sup>  | 15675 | 15816 |
| HSBC Holdings PLC 7.39% 11/3/2028 (USD-SOFR + 7.39% on 11/3/2027) <sup>(a)</sup>  | 1994 | 2111 |
| HSBC Holdings PLC 2.206% 8/17/2029 (USD-SOFR + 1.285% on 8/17/2028) <sup>(a)</sup>  | 41629 | 39535 |
| HSBC Holdings PLC 5.286% 11/19/2030 (USD-SOFR + 1.29% on 11/19/2029) <sup>(a)</sup>  | 5278 | 5461 |
| HSBC Holdings PLC 4.619% 11/6/2031 (USD-SOFR + 1.19% on 11/6/2030) <sup>(a)</sup>  | 7300 | 7349 |
| HSBC Holdings PLC 2.804% 5/24/2032 (USD-SOFR + 1.187% on 5/24/2031) <sup>(a)</sup>  | 267 | 245 |
| HSBC Holdings PLC 5.79% 5/13/2036 (USD-SOFR + 1.88% on 5/13/2035) <sup>(a)</sup>  | 31317 | 33271 |
| HSBC Holdings PLC 5.133% 11/6/2036 (USD-SOFR + 1.43% on 11/6/2035) <sup>(a)</sup>  | 15055 | 15196 |
| Intercontinental Exchange, Inc. 4.20% 3/15/2031  | 9200 | 9213 |
| Intercontinental Exchange, Inc. 5.25% 6/15/2031  | 5781 | 6054 |
| Intesa Sanpaolo SpA 7.778% 6/20/2054 (1-year UST Yield Curve Rate T Note Constant Maturity + 3.90% on <br> 6/20/2053) <sup>(a)(b)</sup>  | 11305 | 13598 |
| JPMorgan Chase & Co. 4.995% 7/22/2030 (USD-SOFR + 1.125% on 7/22/2029) <sup>(a)</sup>  | 28218 | 29043 |
| JPMorgan Chase & Co. 4.603% 10/22/2030 (USD-SOFR + 1.04% on 10/22/2029) <sup>(a)</sup>  | 15434 | 15691 |
| JPMorgan Chase & Co. 4.255% 10/22/2031 (USD-SOFR + 0.93% on 10/22/2030) <sup>(a)</sup>  | 30922 | 30965 |
| JPMorgan Chase & Co. 1.764% 11/19/2031 (3-month USD CME Term SOFR + 1.105% on 11/19/2030) <sup>(a)</sup>  | 17029 | 15166 |
| JPMorgan Chase & Co. 1.953% 2/4/2032 (USD-SOFR + 1.065% on 2/4/2031) <sup>(a)</sup>  | 57051 | 50862 |
| JPMorgan Chase & Co. 2.545% 11/8/2032 (USD-SOFR + 1.18% on 11/8/2031) <sup>(a)</sup>  | 1255 | 1137 |
| JPMorgan Chase & Co. 2.963% 1/25/2033 (USD-SOFR + 1.26% on 1/25/2032) <sup>(a)</sup>  | 3167 | 2924 |
| JPMorgan Chase & Co. 5.336% 1/23/2035 (USD-SOFR + 1.62% on 1/23/2034) <sup>(a)</sup>  | 760 | 795 |
| JPMorgan Chase & Co. 5.294% 7/22/2035 (USD-SOFR + 1.46% on 7/22/2034) <sup>(a)</sup>  | 6882 | 7178 |
| JPMorgan Chase & Co. 4.946% 10/22/2035 (USD-SOFR + 1.34% on 10/22/2034) <sup>(a)</sup>  | 896 | 913 |
| JPMorgan Chase & Co. 5.572% 4/22/2036 (USD-SOFR + 1.68% on 4/22/2035) <sup>(a)</sup>  | 31247 | 33205 |
| JPMorgan Chase & Co. 4.81% 10/22/2036 (USD-SOFR + 1.19% on 10/22/2035) <sup>(a)</sup>  | 84672 | 85175 |
| JPMorgan Chase & Co. 3.882% 7/24/2038 (3-month USD CME Term SOFR + 1.622% on 7/24/2037) <sup>(a)</sup>  | 4759 | 4336 |
| JPMorgan Chase & Co. 5.534% 11/29/2045 (USD-SOFR + 1.55% on 11/29/2044) <sup>(a)</sup>  | 11423 | 11833 |
| JPMorgan Chase & Co. 3.109% 4/22/2051 (USD-SOFR + 2.44% on 4/22/2050) <sup>(a)</sup>  | 8807 | 6150 |
| Marsh & McLennan Cos., Inc. 2.25% 11/15/2030  | 5031 | 4595 |
| Marsh & McLennan Cos., Inc. 5.40% 9/15/2033  | 13230 | 13948 |
| Marsh & McLennan Cos., Inc. 5.00% 3/15/2035  | 59277 | 60309 |
| Marsh & McLennan Cos., Inc. 2.90% 12/15/2051  | 1777 | 1156 |
| Marsh & McLennan Cos., Inc. 5.70% 9/15/2053  | 4113 | 4216 |
| Marsh & McLennan Cos., Inc. 5.40% 3/15/2055  | 19574 | 19192 |
| Mastercard, Inc. 4.55% 3/15/2028  | 16283 | 16583 |
| Mastercard, Inc. 4.95% 3/15/2032  | 7160 | 7468 |
| Mastercard, Inc. 4.875% 5/9/2034  | 15214 | 15679 |
| Mastercard, Inc. 4.55% 1/15/2035  | 14230 | 14323 |
| MetLife, Inc. 5.375% 7/15/2033  | 17216 | 18187 |
| Metropolitan Life Global Funding I 5.05% 1/6/2028 <sup>(b)</sup>  | 6669 | 6813 |
| Metropolitan Life Global Funding I 4.15% 8/25/2028 <sup>(b)</sup>  | 4461 | 4479 |
| Metropolitan Life Global Funding I 2.95% 4/9/2030 <sup>(b)</sup>  | 3778 | 3601 |
| Metropolitan Life Global Funding I 1.55% 1/7/2031 <sup>(b)</sup>  | 17187 | 15139 |
| Mitsubishi UFJ Financial Group, Inc. 4.527% 9/12/2031 (1-year UST Yield Curve Rate T Note Constant Maturity + <br> 1.13% on 9/12/2030) <sup>(a)</sup>  | 8000 | 8070 |
| Morgan Stanley 3.875% 1/27/2026  | 5847 | 5844 |
| Morgan Stanley 4.994% 4/12/2029 (USD-SOFR + 1.38% on 4/12/2028) <sup>(a)</sup>  | 3535 | 3606 |
| Morgan Stanley 6.407% 11/1/2029 (USD-SOFR + 1.83% on 11/1/2028) <sup>(a)</sup>  | 1404 | 1491 |
| Morgan Stanley 5.656% 4/18/2030 (USD-SOFR + 1.26% on 4/18/2029) <sup>(a)</sup>  | 4647 | 4858 |
| Morgan Stanley 4.654% 10/18/2030 (USD-SOFR + 1.10% on 10/18/2029) <sup>(a)</sup>  | 8640 | 8770 |
| Morgan Stanley 5.23% 1/15/2031 (USD-SOFR + 1.108% on 1/15/2030) <sup>(a)</sup>  | 20475 | 21183 |
| Morgan Stanley 5.192% 4/17/2031 (USD-SOFR + 1.51% on 4/17/2030) <sup>(a)</sup>  | 22162 | 22944 |
| Morgan Stanley 4.356% 10/22/2031 (USD-SOFR + 1.074% on 10/22/2030) <sup>(a)</sup>  | 82678 | 82785 |

---

Capital Group Central Corporate Bond Fund<sub>2</sub>

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Financials (continued)** | **Financials (continued)** | **Financials (continued)** |
| Morgan Stanley 1.794% 2/13/2032 (USD-SOFR + 1.034% on 2/13/2031) <sup>(a)</sup>  | USD18,596 | $16394 |
| Morgan Stanley 1.928% 4/28/2032 (USD-SOFR + 1.02% on 4/28/2031) <sup>(a)</sup>  | 1062 | 936 |
| Morgan Stanley 5.32% 7/19/2035 (USD-SOFR + 1.555% on 7/19/2034) <sup>(a)</sup>  | 9042 | 9394 |
| Morgan Stanley 4.892% 10/22/2036 (USD-SOFR + 1.314% on 10/22/2035) <sup>(a)</sup>  | 81718 | 82015 |
| National Rural Utilities Cooperative Finance Corp. 3.05% 4/25/2027  | 1875 | 1854 |
| New York Life Global Funding 2.35% 7/14/2026 <sup>(b)</sup>  | 3570 | 3536 |
| New York Life Global Funding 4.60% 12/5/2029 <sup>(b)</sup>  | 15123 | 15417 |
| New York Life Global Funding 1.20% 8/7/2030 <sup>(b)</sup>  | 10498 | 9197 |
| New York Life Global Funding 4.55% 1/28/2033 <sup>(b)</sup>  | 3788 | 3796 |
| Northwestern Mutual Global Funding 4.125% 8/25/2028 <sup>(b)</sup>  | 13130 | 13193 |
| PNC Bank, NA 4.543% 5/13/2027 (USD-SOFR + 0.63% on 5/13/2026) <sup>(a)</sup>  | 10322 | 10338 |
| PNC Bank, NA 5.373% 7/21/2036 (USD-SOFR + 1.417% on 7/21/2035) <sup>(a)</sup>  | 6461 | 6696 |
| PNC Financial Services Group, Inc. 5.582% 6/12/2029 (USD-SOFR + 1.841% on 6/12/2028) <sup>(a)</sup>  | 12214 | 12666 |
| PNC Financial Services Group, Inc. 5.222% 1/29/2031 (USD-SOFR + 1.072% on 1/29/2030) <sup>(a)</sup>  | 21946 | 22769 |
| PNC Financial Services Group, Inc. 6.875% 10/20/2034 (USD-SOFR + 2.284% on 10/20/2033) <sup>(a)</sup>  | 16159 | 18379 |
| PNC Financial Services Group, Inc. 5.575% 1/29/2036 (USD-SOFR + 1.394% on 1/29/2035) <sup>(a)</sup>  | 10929 | 11498 |
| Royal Bank of Canada 5.153% 2/4/2031 (USD-SOFR + 1.03% on 2/4/2030) <sup>(a)</sup>  | 26495 | 27399 |
| Royal Bank of Canada 4.696% 8/6/2031 (USD-SOFR + 1.06% on 8/6/2030) <sup>(a)</sup>  | 13005 | 13223 |
| Sumitomo Mitsui Financial Group, Inc. 5.88% 7/13/2026  | 18475 | 18682 |
| Sumitomo Mitsui Financial Group, Inc. 5.80% 7/13/2028  | 6207 | 6479 |
| Sumitomo Mitsui Financial Group, Inc. 5.776% 7/13/2033  | 10601 | 11397 |
| Toronto-Dominion Bank (The) 4.861% 1/31/2028  | 5686 | 5787 |
| Toronto-Dominion Bank (The) 4.808% 6/3/2030  | 7000 | 7162 |
| Travelers Cos., Inc. 5.05% 7/24/2035  | 4495 | 4602 |
| Travelers Cos., Inc. 4.00% 5/30/2047  | 3885 | 3205 |
| Travelers Cos., Inc. 4.05% 3/7/2048  | 2753 | 2279 |
| Travelers Cos., Inc. 2.55% 4/27/2050  | 859 | 534 |
| Travelers Cos., Inc. 5.45% 5/25/2053  | 4404 | 4426 |
| Travelers Cos., Inc. 5.70% 7/24/2055  | 1878 | 1954 |
| Truist Financial Corp. 5.071% 5/20/2031 (USD-SOFR + 1.309% on 5/20/2030) <sup>(a)</sup>  | 19878 | 20465 |
| U.S. Bancorp 5.046% 2/12/2031 (USD-SOFR + 1.061% on 2/12/2030) <sup>(a)</sup>  | 8878 | 9149 |
| U.S. Bancorp 5.424% 2/12/2036 (USD-SOFR + 1.411% on 2/12/2035) <sup>(a)</sup>  | 11206 | 11721 |
| UBS Group AG 1.364% 1/30/2027 (5-year UST Yield Curve Rate T Note Constant Maturity + 1.08% on <br>1/30/2026) <sup>(a)(b)</sup>  | 2049 | 2039 |
| UBS Group AG 1.305% 2/2/2027 (USD-SOFR + 0.98% on 2/2/2026) <sup>(a)(b)</sup>  | 250 | 249 |
| UBS Group AG 5.617% 9/13/2030 (1-year USD-ICE SOFR Swap + 1.34% on 9/13/2029) <sup>(a)(b)</sup>  | 8730 | 9144 |
| UBS Group AG 2.095% 2/11/2032 (1-year UST Yield Curve Rate T Note Constant Maturity + 1.00% on <br>2/11/2031) <sup>(a)(b)</sup>  | 3405 | 3031 |
| UBS Group AG 3.091% 5/14/2032 (USD-SOFR + 1.73% on 5/14/2031) <sup>(a)(b)</sup>  | 9670 | 9016 |
| Wells Fargo & Co. 5.15% 4/23/2031 (USD-SOFR + 1.50% on 4/23/2030) <sup>(a)</sup>  | 52413 | 54297 |
| Wells Fargo & Co. 3.35% 3/2/2033 (USD-SOFR + 1.50% on 3/2/2032) <sup>(a)</sup>  | 823 | 774 |
| Wells Fargo & Co. 5.557% 7/25/2034 (USD-SOFR + 1.99% on 7/25/2033) <sup>(a)</sup>  | 11847 | 12552 |
| Wells Fargo & Co. 6.491% 10/23/2034 (USD-SOFR + 2.06% on 10/23/2033) <sup>(a)</sup>  | 36 | 40 |
| Wells Fargo & Co. 5.211% 12/3/2035 (USD-SOFR + 1.38% on 12/3/2034) <sup>(a)</sup>  | 4771 | 4929 |
| Wells Fargo & Co. 5.605% 4/23/2036 (USD-SOFR + 1.74% on 4/23/2035) <sup>(a)</sup>  | 7700 | 8170 |
| Wells Fargo & Co. 4.611% 4/25/2053 (USD-SOFR + 2.13% on 4/25/2052) <sup>(a)</sup>  | 22017 | 19420 |
|  |  | 2424536 |
| **Health care 14.37%** | **Health care 14.37%** | **Health care 14.37%** |
| AbbVie, Inc. 2.95% 11/21/2026  | 23238 | 23025 |
| AbbVie, Inc. 4.95% 3/15/2031  | 20850 | 21666 |
| AbbVie, Inc. 5.05% 3/15/2034  | 66997 | 69509 |
| AbbVie, Inc. 5.20% 3/15/2035  | 17624 | 18407 |
| AbbVie, Inc. 5.35% 3/15/2044  | 2869 | 2891 |
| AbbVie, Inc. 5.40% 3/15/2054  | 20079 | 20030 |
| AbbVie, Inc. 5.50% 3/15/2064  | 3095 | 3087 |
| Amgen, Inc. 2.20% 2/21/2027  | 3010 | 2945 |
| Amgen, Inc. 5.15% 3/2/2028  | 14926 | 15280 |
| Amgen, Inc. 3.00% 2/22/2029  | 2882 | 2793 |
| Amgen, Inc. 4.05% 8/18/2029  | 3633 | 3629 |
| Amgen, Inc. 2.45% 2/21/2030  | 4687 | 4372 |
| Amgen, Inc. 2.30% 2/25/2031  | 4687 | 4256 |
| Amgen, Inc. 2.00% 1/15/2032  | 12963 | 11322 |
| Amgen, Inc. 4.20% 3/1/2033  | 43000 | 42271 |
| Amgen, Inc. 5.25% 3/2/2033  | 51896 | 54105 |

---

---

| | |
|:---|:---|
| **3** | Capital Group Central Corporate Bond Fund |

---

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Health care (continued)** | **Health care (continued)** | **Health care (continued)** |
| Amgen, Inc. 3.15% 2/21/2040  | USD2,636 | $2110 |
| Amgen, Inc. 5.60% 3/2/2043  | 8782 | 8979 |
| Amgen, Inc. 4.20% 2/22/2052  | 2036 | 1653 |
| Amgen, Inc. 4.875% 3/1/2053  | 5975 | 5378 |
| Amgen, Inc. 5.65% 3/2/2053  | 17559 | 17655 |
| Amgen, Inc. 4.40% 2/22/2062  | 5748 | 4622 |
| AstraZeneca PLC 4.00% 1/17/2029  | 4920 | 4936 |
| Baxter International, Inc. 4.45% 2/15/2029  | 3836 | 3854 |
| Baxter International, Inc. 2.539% 2/1/2032  | 10004 | 8748 |
| Baxter International, Inc. 5.65% 12/15/2035  | 25285 | 25779 |
| Baxter International, Inc. 3.132% 12/1/2051  | 5401 | 3479 |
| Bristol-Myers Squibb Co. 5.20% 2/22/2034  | 76118 | 79908 |
| Bristol-Myers Squibb Co. 2.55% 11/13/2050  | 6857 | 4170 |
| Bristol-Myers Squibb Co. 3.70% 3/15/2052  | 7133 | 5394 |
| Bristol-Myers Squibb Co. 5.55% 2/22/2054  | 44694 | 45187 |
| Centene Corp. 4.25% 12/15/2027  | 3446 | 3406 |
| Centene Corp. 2.45% 7/15/2028  | 20239 | 18884 |
| Centene Corp. 4.625% 12/15/2029  | 6180 | 5979 |
| Cigna Group (The) 5.25% 1/15/2036  | 19245 | 19741 |
| Cigna Group (The) 6.00% 1/15/2056  | 8722 | 9112 |
| CVS Health Corp. 1.30% 8/21/2027  | 10000 | 9538 |
| CVS Health Corp. 3.25% 8/15/2029  | 4775 | 4613 |
| CVS Health Corp. 1.75% 8/21/2030  | 7924 | 7048 |
| CVS Health Corp. 1.875% 2/28/2031  | 14560 | 12809 |
| CVS Health Corp. 5.00% 9/15/2032  | 20261 | 20768 |
| CVS Health Corp. 5.25% 2/21/2033  | 20879 | 21613 |
| CVS Health Corp. 5.70% 6/1/2034  | 26517 | 27944 |
| CVS Health Corp. 5.45% 9/15/2035  | 34529 | 35654 |
| CVS Health Corp. 6.05% 6/1/2054  | 8315 | 8435 |
| CVS Health Corp. 6.20% 9/15/2055  | 43391 | 44994 |
| CVS Health Corp. 6.00% 6/1/2063  | 2447 | 2417 |
| CVS Health Corp. 6.25% 9/15/2065  | 9595 | 9835 |
| Elevance Health, Inc. 5.20% 2/15/2035  | 5110 | 5243 |
| Elevance Health, Inc. 5.00% 1/15/2036  | 3190 | 3197 |
| Elevance Health, Inc. 4.55% 5/15/2052  | 7712 | 6501 |
| Elevance Health, Inc. 5.125% 2/15/2053  | 2695 | 2472 |
| Elevance Health, Inc. 5.70% 2/15/2055  | 2698 | 2675 |
| Elevance Health, Inc. 5.85% 11/1/2064  | 3365 | 3347 |
| Eli Lilly and Co. 4.50% 2/9/2027  | 27875 | 28106 |
| Eli Lilly and Co. 3.375% 3/15/2029  | 2764 | 2727 |
| Eli Lilly and Co. 4.60% 8/14/2034  | 12985 | 13153 |
| Eli Lilly and Co. 5.10% 2/12/2035  | 36117 | 37737 |
| Eli Lilly and Co. 4.90% 10/15/2035  | 6360 | 6538 |
| Eli Lilly and Co. 5.50% 2/12/2055  | 25158 | 25859 |
| Eli Lilly and Co. 5.55% 10/15/2055  | 1437 | 1485 |
| Eli Lilly and Co. 5.65% 10/15/2065  | 1394 | 1444 |
| Gilead Sciences, Inc. 5.25% 10/15/2033  | 35515 | 37518 |
| Gilead Sciences, Inc. 2.80% 10/1/2050  | 1414 | 919 |
| Gilead Sciences, Inc. 5.55% 10/15/2053  | 21145 | 21536 |
| HCA, Inc. 4.125% 6/15/2029  | 2250 | 2246 |
| HCA, Inc. 2.375% 7/15/2031  | 8178 | 7340 |
| HCA, Inc. 3.625% 3/15/2032  | 6778 | 6431 |
| HCA, Inc. 4.625% 3/15/2052  | 6531 | 5463 |
| Humana, Inc. 5.375% 4/15/2031  | 13935 | 14421 |
| Humana, Inc. 5.55% 5/1/2035  | 6750 | 6931 |
| Humana, Inc. 6.00% 5/1/2055  | 9175 | 9111 |
| Johnson & Johnson 4.55% 3/1/2028  | 6725 | 6851 |
| Johnson & Johnson 4.90% 6/1/2031  | 13447 | 14107 |
| Johnson & Johnson 4.85% 3/1/2032  | 22003 | 22966 |
| Johnson & Johnson 4.95% 6/1/2034  | 20170 | 21359 |
| Johnson & Johnson 5.00% 3/1/2035  | 11576 | 12154 |
| Johnson & Johnson 2.25% 9/1/2050  | 1087 | 659 |
| Johnson & Johnson 5.25% 6/1/2054  | 3620 | 3708 |
| Pfizer Investment Enterprises Pte., Ltd. 4.45% 5/19/2028  | 4294 | 4347 |
| Pfizer Investment Enterprises Pte., Ltd. 4.75% 5/19/2033  | 5000 | 5099 |
| Pfizer Investment Enterprises Pte., Ltd. 5.30% 5/19/2053  | 65138 | 63180 |

---

Capital Group Central Corporate Bond Fund<sub>4</sub>

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Health care (continued)** | **Health care (continued)** | **Health care (continued)** |
| Pfizer, Inc. 3.45% 3/15/2029  | USD6,525 | $6455 |
| Pfizer, Inc. 1.70% 5/28/2030  | 13275 | 12044 |
| Roche Holdings, Inc. 2.076% 12/13/2031 <sup>(b)</sup>  | 29252 | 25978 |
| Roche Holdings, Inc. 5.593% 11/13/2033 <sup>(b)</sup>  | 17864 | 19258 |
| Roche Holdings, Inc. 4.592% 9/9/2034 <sup>(b)</sup>  | 2946 | 2966 |
| Roche Holdings, Inc. 5.218% 3/8/2054 <sup>(b)</sup>  | 3757 | 3713 |
| Shire Acquisitions Investments Ireland DAC 3.20% 9/23/2026  | 109 | 108 |
| Stryker Corp. 5.20% 2/10/2035  | 24850 | 25789 |
| Takeda U.S. Financing, Inc. 5.20% 7/7/2035  | 69251 | 71082 |
| Takeda U.S. Financing, Inc. 5.90% 7/7/2055  | 15095 | 15701 |
| Thermo Fisher Scientific, Inc. (The) 4.20% 3/1/2031  | 26720 | 26770 |
| Thermo Fisher Scientific, Inc. (The) 4.794% 10/7/2035  | 8051 | 8135 |
| UnitedHealth Group, Inc. 1.25% 1/15/2026  | 9393 | 9358 |
| UnitedHealth Group, Inc. 3.875% 12/15/2028  | 1875 | 1872 |
| UnitedHealth Group, Inc. 2.875% 8/15/2029  | 285 | 274 |
| UnitedHealth Group, Inc. 2.00% 5/15/2030  | 5765 | 5276 |
| UnitedHealth Group, Inc. 4.20% 5/15/2032  | 3952 | 3925 |
| UnitedHealth Group, Inc. 5.35% 2/15/2033  | 5556 | 5827 |
| UnitedHealth Group, Inc. 5.15% 7/15/2034  | 15045 | 15564 |
| UnitedHealth Group, Inc. 5.30% 6/15/2035  | 41660 | 43430 |
| UnitedHealth Group, Inc. 3.05% 5/15/2041  | 12150 | 9353 |
| UnitedHealth Group, Inc. 4.45% 12/15/2048  | 13315 | 11462 |
| UnitedHealth Group, Inc. 3.70% 8/15/2049  | 2760 | 2095 |
| UnitedHealth Group, Inc. 3.25% 5/15/2051  | 7753 | 5366 |
| UnitedHealth Group, Inc. 4.75% 5/15/2052  | 16756 | 14818 |
| UnitedHealth Group, Inc. 5.625% 7/15/2054  | 20791 | 20843 |
| UnitedHealth Group, Inc. 5.95% 6/15/2055  | 17044 | 17874 |
| UnitedHealth Group, Inc. 4.95% 5/15/2062  | 3590 | 3182 |
| UnitedHealth Group, Inc. 6.05% 2/15/2063  | 4160 | 4356 |
| Viatris, Inc. 4.00% 6/22/2050  | 14757 | 9903 |
|  |  | 1593837 |
| **Utilities 11.53%** | **Utilities 11.53%** | **Utilities 11.53%** |
| AEP Texas, Inc. 3.45% 5/15/2051  | 3894 | 2698 |
| AEP Transmission Co., LLC 5.15% 4/1/2034  | 2919 | 3006 |
| AEP Transmission Co., LLC 5.375% 6/15/2035  | 1250 | 1303 |
| Alabama Power Co. 5.85% 11/15/2033  | 3075 | 3330 |
| Ameren Corp. 1.75% 3/15/2028  | 5655 | 5367 |
| American Transmission Systems, Inc. 2.65% 1/15/2032 <sup>(b)</sup>  | 20450 | 18525 |
| Atlantic City Electric Co. 2.30% 3/15/2031  | 2175 | 1975 |
| Berkshire Hathaway Energy Co. 1.65% 5/15/2031  | 7533 | 6578 |
| CenterPoint Energy Houston Electric, LLC 5.05% 3/1/2035  | 5006 | 5113 |
| CMS Energy Corp. 3.00% 5/15/2026  | 3750 | 3730 |
| Commonwealth Edison Co. 2.95% 8/15/2027  | 3750 | 3697 |
| Commonwealth Edison Co. 3.125% 3/15/2051  | 1500 | 1023 |
| Commonwealth Edison Co. 2.75% 9/1/2051  | 1202 | 764 |
| Connecticut Light and Power Co. (The) 2.05% 7/1/2031  | 10783 | 9627 |
| Consumers Energy Co. 3.80% 11/15/2028  | 2306 | 2301 |
| Consumers Energy Co. 4.50% 1/15/2031  | 24344 | 24689 |
| Consumers Energy Co. 3.60% 8/15/2032  | 14216 | 13609 |
| Consumers Energy Co. 4.625% 5/15/2033  | 11180 | 11304 |
| Consumers Energy Co. 5.05% 5/15/2035  | 25499 | 26158 |
| DTE Electric Co. 5.25% 5/15/2035  | 6775 | 7020 |
| Duke Energy Carolinas, LLC 3.70% 12/1/2047  | 777 | 604 |
| Duke Energy Carolinas, LLC 3.20% 8/15/2049  | 1245 | 866 |
| Duke Energy Carolinas, LLC 5.35% 1/15/2053  | 15801 | 15479 |
| Duke Energy Corp. 4.95% 9/15/2035  | 6475 | 6474 |
| Duke Energy Corp. 5.00% 8/15/2052  | 4223 | 3815 |
| Duke Energy Florida, LLC 3.20% 1/15/2027  | 2593 | 2576 |
| Duke Energy Florida, LLC 1.75% 6/15/2030  | 12027 | 10861 |
| Duke Energy Florida, LLC 5.875% 11/15/2033  | 2 | 2 |
| Duke Energy Florida, LLC 4.85% 12/1/2035  | 14903 | 14988 |
| Duke Energy Progress, LLC 2.00% 8/15/2031  | 8945 | 7953 |
| Duke Energy Progress, LLC 2.50% 8/15/2050  | 1582 | 956 |
| Duke Energy Progress, LLC 2.90% 8/15/2051  | 6618 | 4282 |

---

---

| | |
|:---|:---|
| **5** | Capital Group Central Corporate Bond Fund |

---

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Utilities (continued)** | **Utilities (continued)** | **Utilities (continued)** |
| Edison International 4.125% 3/15/2028  | USD14,156 | $13996 |
| Edison International 5.25% 11/15/2028  | 451 | 458 |
| Edison International 5.45% 6/15/2029  | 7217 | 7342 |
| Edison International 6.95% 11/15/2029  | 17343 | 18480 |
| Edison International 6.25% 3/15/2030  | 33544 | 35081 |
| Edison International 5.25% 3/15/2032  | 7602 | 7614 |
| Electricite de France SA 9.125% junior subordinated perpetual bonds (5-year UST Yield Curve Rate T <br> Note Constant Maturity + 5.411% on 6/15/2033) <sup>(a)(b)</sup>  | 11086 | 12856 |
| Emera US Finance, LP 2.639% 6/15/2031  | 6743 | 6069 |
| Enel Finance International NV 5.00% 9/30/2035 <sup>(b)</sup>  | 8200 | 8186 |
| Entergy Corp. 2.40% 6/15/2031  | 9206 | 8294 |
| Entergy Corp. 3.75% 6/15/2050  | 1256 | 933 |
| Entergy Louisiana, LLC 3.12% 9/1/2027  | 4481 | 4421 |
| Eversource Energy 4.45% 12/15/2030  | 11290 | 11264 |
| Eversource Energy 5.85% 4/15/2031  | 2750 | 2906 |
| Eversource Energy 3.375% 3/1/2032  | 3478 | 3225 |
| FirstEnergy Corp. 2.25% 9/1/2030  | 12303 | 11170 |
| Florida Power & Light Co. 5.10% 4/1/2033  | 13744 | 14333 |
| Florida Power & Light Co. 5.30% 6/15/2034  | 31777 | 33444 |
| Florida Power & Light Co. 3.70% 12/1/2047  | 4710 | 3701 |
| Florida Power & Light Co. 3.15% 10/1/2049  | 728 | 513 |
| Florida Power & Light Co. 2.875% 12/4/2051  | 29281 | 19104 |
| Florida Power & Light Co. 5.30% 4/1/2053  | 4377 | 4303 |
| Florida Power & Light Co. 5.70% 3/15/2055  | 11121 | 11568 |
| Jersey Central Power & Light Co. 2.75% 3/1/2032 <sup>(b)</sup>  | 13150 | 11865 |
| Jersey Central Power & Light Co. 5.10% 1/15/2035  | 6075 | 6176 |
| MidAmerican Energy Co. 6.75% 12/30/2031  | 2259 | 2562 |
| MidAmerican Energy Co. 5.50% 11/15/2056  | 7000 | 6986 |
| NextEra Energy Capital Holdings, Inc. 4.685% 9/1/2027  | 4300 | 4347 |
| Northern States Power Co. 5.05% 5/15/2035  | 1838 | 1892 |
| Northern States Power Co. 5.10% 5/15/2053  | 1479 | 1402 |
| Northern States Power Co. 5.40% 3/15/2054  | 10584 | 10506 |
| Northern States Power Co. 5.65% 5/15/2055  | 665 | 683 |
| Pacific Gas and Electric Co. 3.15% 1/1/2026  | 8438 | 8427 |
| Pacific Gas and Electric Co. 2.10% 8/1/2027  | 12094 | 11668 |
| Pacific Gas and Electric Co. 5.00% 6/4/2028  | 19030 | 19348 |
| Pacific Gas and Electric Co. 4.55% 7/1/2030  | 29509 | 29421 |
| Pacific Gas and Electric Co. 2.50% 2/1/2031  | 61459 | 55321 |
| Pacific Gas and Electric Co. 4.40% 3/1/2032  | 4422 | 4317 |
| Pacific Gas and Electric Co. 5.90% 6/15/2032  | 3933 | 4143 |
| Pacific Gas and Electric Co. 5.05% 10/15/2032  | 3276 | 3299 |
| Pacific Gas and Electric Co. 6.15% 1/15/2033  | 4826 | 5149 |
| Pacific Gas and Electric Co. 6.40% 6/15/2033  | 25843 | 28059 |
| Pacific Gas and Electric Co. 6.95% 3/15/2034  | 16074 | 18006 |
| Pacific Gas and Electric Co. 5.70% 3/1/2035  | 59186 | 61247 |
| Pacific Gas and Electric Co. 6.00% 8/15/2035  | 17695 | 18712 |
| Pacific Gas and Electric Co. 3.30% 8/1/2040  | 21380 | 16382 |
| Pacific Gas and Electric Co. 4.95% 7/1/2050  | 13491 | 11658 |
| Pacific Gas and Electric Co. 3.50% 8/1/2050  | 4980 | 3432 |
| PacifiCorp 2.70% 9/15/2030  | 5754 | 5309 |
| PacifiCorp 5.30% 2/15/2031  | 14335 | 14812 |
| PacifiCorp 5.45% 2/15/2034  | 3941 | 4029 |
| PacifiCorp 4.125% 1/15/2049  | 1239 | 948 |
| PacifiCorp 3.30% 3/15/2051  | 12845 | 8361 |
| PacifiCorp 2.90% 6/15/2052  | 11320 | 6763 |
| PacifiCorp 5.35% 12/1/2053  | 9570 | 8564 |
| PacifiCorp 5.50% 5/15/2054  | 27968 | 25572 |
| PacifiCorp 5.80% 1/15/2055  | 9497 | 9042 |
| PECO Energy Co. 4.875% 9/15/2035  | 26940 | 27345 |
| PECO Energy Co. 5.25% 9/15/2054  | 8325 | 8056 |
| PECO Energy Co. 5.65% 9/15/2055  | 4995 | 5106 |
| Progress Energy, Inc. 7.00% 10/30/2031  | 4675 | 5287 |
| Public Service Electric and Gas Co. 0.95% 3/15/2026  | 5689 | 5637 |
| Public Service Electric and Gas Co. 3.65% 9/1/2028  | 1586 | 1576 |
| Public Service Electric and Gas Co. 2.45% 1/15/2030  | 4389 | 4138 |
| Public Service Electric and Gas Co. 1.90% 8/15/2031  | 9526 | 8443 |

---

Capital Group Central Corporate Bond Fund<sub>6</sub>

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Utilities (continued)** | **Utilities (continued)** | **Utilities (continued)** |
| Public Service Electric and Gas Co. 5.20% 8/1/2033  | USD2,341 | $2448 |
| Public Service Electric and Gas Co. 4.85% 8/1/2034  | 1187 | 1207 |
| Public Service Electric and Gas Co. 4.90% 8/15/2035  | 39560 | 40173 |
| Public Service Electric and Gas Co. 3.20% 8/1/2049  | 3021 | 2134 |
| Public Service Electric and Gas Co. 2.70% 5/1/2050  | 3595 | 2296 |
| Public Service Electric and Gas Co. 2.05% 8/1/2050  | 6374 | 3540 |
| Public Service Electric and Gas Co. 3.00% 3/1/2051  | 1211 | 821 |
| Public Service Electric and Gas Co. 5.125% 3/15/2053  | 1734 | 1662 |
| Public Service Electric and Gas Co. 5.30% 8/1/2054  | 2300 | 2256 |
| Public Service Enterprise Group, Inc. 5.40% 3/15/2035  | 10275 | 10648 |
| Southern California Edison Co. 3.65% 3/1/2028  | 8458 | 8347 |
| Southern California Edison Co. 5.65% 10/1/2028  | 19395 | 20081 |
| Southern California Edison Co. 5.15% 6/1/2029  | 95 | 97 |
| Southern California Edison Co. 2.85% 8/1/2029  | 28218 | 26656 |
| Southern California Edison Co. 2.25% 6/1/2030  | 8067 | 7312 |
| Southern California Edison Co. 2.50% 6/1/2031  | 7623 | 6840 |
| Southern California Edison Co. 5.45% 6/1/2031  | 6061 | 6271 |
| Southern California Edison Co. 5.95% 11/1/2032  | 1585 | 1685 |
| Southern California Edison Co. 5.20% 6/1/2034  | 916 | 925 |
| Southern California Edison Co. 5.45% 3/1/2035  | 3457 | 3533 |
| Southern California Edison Co. 5.625% 2/1/2036  | 228 | 233 |
| Southern California Edison Co. 4.50% 9/1/2040  | 16024 | 14250 |
| Southern California Edison Co. 3.60% 2/1/2045  | 7883 | 5808 |
| Southern California Edison Co. 4.00% 4/1/2047  | 7650 | 5870 |
| Southern California Edison Co. 3.65% 2/1/2050  | 6265 | 4448 |
| Southern California Edison Co. 2.95% 2/1/2051  | 19306 | 12053 |
| Southern California Edison Co. 3.45% 2/1/2052  | 12608 | 8563 |
| Southern California Edison Co. 5.75% 4/15/2054  | 1250 | 1203 |
| Southern California Edison Co. 6.20% 9/15/2055  | 36660 | 37664 |
| Southern Co. (The) 4.85% 3/15/2035  | 2891 | 2881 |
| Southwestern Electric Power Co. 3.25% 11/1/2051  | 6450 | 4333 |
| Union Electric Co. 5.25% 4/15/2035  | 13900 | 14461 |
| Union Electric Co. 2.625% 3/15/2051  | 3600 | 2208 |
| Union Electric Co. 5.125% 3/15/2055  | 8995 | 8471 |
| WEC Energy Group, Inc. 5.15% 10/1/2027  | 2432 | 2479 |
| Wisconsin Electric Power Co. 4.60% 10/1/2034  | 4481 | 4491 |
| Wisconsin Electric Power Co. 5.05% 10/1/2054  | 744 | 703 |
| Wisconsin Power and Light Co. 1.95% 9/16/2031  | 2625 | 2309 |
| Wisconsin Power and Light Co. 3.65% 4/1/2050  | 600 | 446 |
| Wisconsin Public Service Corp. 2.85% 12/1/2051  | 9803 | 6338 |
| Xcel Energy, Inc. 2.35% 11/15/2031  | 5525 | 4931 |
| Xcel Energy, Inc. 5.45% 8/15/2033  | 6382 | 6640 |
| Xcel Energy, Inc. 5.50% 3/15/2034  | 25 | 26 |
| Xcel Energy, Inc. 5.60% 4/15/2035  | 24490 | 25521 |
|  |  | 1279192 |
| **Communication services 6.48%** | **Communication services 6.48%** | **Communication services 6.48%** |
| Alphabet, Inc. 4.375% 11/15/2032  | 7859 | 7957 |
| Alphabet, Inc. 4.70% 11/15/2035  | 15635 | 15894 |
| Alphabet, Inc. 5.25% 5/15/2055  | 1471 | 1463 |
| Alphabet, Inc. 5.45% 11/15/2055  | 1234 | 1255 |
| Alphabet, Inc. 5.30% 5/15/2065  | 2025 | 1993 |
| AT&T, Inc. 2.30% 6/1/2027  | 1221 | 1190 |
| AT&T, Inc. 4.35% 3/1/2029  | 19002 | 19114 |
| AT&T, Inc. 4.30% 2/15/2030  | 15022 | 15109 |
| AT&T, Inc. 2.25% 2/1/2032  | 12533 | 11057 |
| AT&T, Inc. 2.55% 12/1/2033  | 7369 | 6325 |
| AT&T, Inc. 5.40% 2/15/2034  | 20914 | 21850 |
| AT&T, Inc. 4.50% 5/15/2035  | 8216 | 7984 |
| AT&T, Inc. 3.50% 9/15/2053  | 60036 | 41345 |
| Charter Communications Operating, LLC 3.75% 2/15/2028  | 1050 | 1035 |
| Charter Communications Operating, LLC 4.20% 3/15/2028  | 2959 | 2943 |
| Charter Communications Operating, LLC 2.80% 4/1/2031  | 3648 | 3279 |
| Charter Communications Operating, LLC 4.40% 4/1/2033  | 6000 | 5659 |
| Charter Communications Operating, LLC 5.85% 12/1/2035  | 11214 | 11245 |

---

---

| | |
|:---|:---|
| **7** | Capital Group Central Corporate Bond Fund |

---

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Communication services (continued)** | **Communication services (continued)** | **Communication services (continued)** |
| Charter Communications Operating, LLC 4.80% 3/1/2050  | USD21,382 | $16444 |
| Charter Communications Operating, LLC 3.70% 4/1/2051  | 54086 | 34840 |
| Charter Communications Operating, LLC 3.90% 6/1/2052  | 63482 | 41711 |
| Charter Communications Operating, LLC 5.25% 4/1/2053  | 49690 | 40302 |
| Charter Communications Operating, LLC 6.70% 12/1/2055  | 7900 | 7706 |
| Comcast Corp. 4.80% 5/15/2033  | 6091 | 6170 |
| Comcast Corp. 5.30% 6/1/2034  | 6177 | 6382 |
| Comcast Corp. 5.30% 5/15/2035  | 9162 | 9447 |
| Comcast Corp. 5.65% 6/1/2054  | 30581 | 29351 |
| Comcast Corp. 6.05% 5/15/2055  | 5552 | 5624 |
| Meta Platforms, Inc. 4.20% 11/15/2030  | 13402 | 13498 |
| Meta Platforms, Inc. 4.60% 11/15/2032  | 6368 | 6465 |
| Meta Platforms, Inc. 4.875% 11/15/2035  | 39140 | 39579 |
| Meta Platforms, Inc. 5.50% 11/15/2045  | 14976 | 14990 |
| Meta Platforms, Inc. 5.625% 11/15/2055  | 17261 | 17230 |
| Meta Platforms, Inc. 5.75% 11/15/2065  | 7939 | 7911 |
| T-Mobile USA, Inc. 1.50% 2/15/2026  | 5250 | 5221 |
| T-Mobile USA, Inc. 2.05% 2/15/2028  | 2185 | 2094 |
| T-Mobile USA, Inc. 3.875% 4/15/2030  | 14841 | 14622 |
| T-Mobile USA, Inc. 2.55% 2/15/2031  | 7659 | 7019 |
| T-Mobile USA, Inc. 5.125% 5/15/2032  | 3699 | 3830 |
| T-Mobile USA, Inc. 5.15% 4/15/2034  | 1677 | 1726 |
| T-Mobile USA, Inc. 3.00% 2/15/2041  | 9938 | 7503 |
| T-Mobile USA, Inc. 3.40% 10/15/2052  | 23466 | 16152 |
| T-Mobile USA, Inc. 5.75% 1/15/2054  | 5653 | 5666 |
| T-Mobile USA, Inc. 5.50% 1/15/2055  | 3690 | 3571 |
| T-Mobile USA, Inc. 5.875% 11/15/2055  | 7749 | 7902 |
| Verizon Communications, Inc. 1.75% 1/20/2031  | 10248 | 9043 |
| Verizon Communications, Inc. 2.55% 3/21/2031  | 2849 | 2607 |
| Verizon Communications, Inc. 2.355% 3/15/2032  | 455 | 402 |
| Verizon Communications, Inc. 4.78% 2/15/2035  | 32723 | 32482 |
| Verizon Communications, Inc. 5.25% 4/2/2035  | 22612 | 23194 |
| Verizon Communications, Inc. 5.00% 1/15/2036  | 35449 | 35511 |
| Verizon Communications, Inc. 5.401% 7/2/2037 <sup>(b)</sup>  | 19436 | 19892 |
| Verizon Communications, Inc. 3.40% 3/22/2041  | 9712 | 7694 |
| Verizon Communications, Inc. 2.85% 9/3/2041  | 991 | 724 |
| Verizon Communications, Inc. 5.75% 11/30/2045  | 9556 | 9644 |
| Verizon Communications, Inc. 3.875% 3/1/2052  | 784 | 596 |
| Verizon Communications, Inc. 5.875% 11/30/2055  | 10925 | 11035 |
| Verizon Communications, Inc. 2.987% 10/30/2056  | 13117 | 8022 |
| Verizon Communications, Inc. 6.00% 11/30/2065  | 8633 | 8738 |
|  |  | 719237 |
| **Industrials 6.44%** | **Industrials 6.44%** | **Industrials 6.44%** |
| BAE Systems PLC 5.30% 3/26/2034 <sup>(b)</sup>  | 46170 | 48185 |
| BAE Systems PLC 5.50% 3/26/2054 <sup>(b)</sup>  | 2623 | 2685 |
| Boeing Co. (The) 2.75% 2/1/2026  | 39990 | 39877 |
| Boeing Co. (The) 2.196% 2/4/2026  | 25000 | 24900 |
| Boeing Co. (The) 3.10% 5/1/2026  | 7750 | 7714 |
| Boeing Co. (The) 5.04% 5/1/2027  | 2000 | 2020 |
| Boeing Co. (The) 3.25% 2/1/2028  | 32764 | 32192 |
| Boeing Co. (The) 6.298% 5/1/2029  | 2000 | 2128 |
| Boeing Co. (The) 5.15% 5/1/2030  | 20913 | 21561 |
| Boeing Co. (The) 3.625% 2/1/2031  | 4658 | 4480 |
| Boeing Co. (The) 6.388% 5/1/2031  | 31681 | 34496 |
| Boeing Co. (The) 6.528% 5/1/2034  | 7158 | 7963 |
| Boeing Co. (The) 3.90% 5/1/2049  | 8164 | 6183 |
| Boeing Co. (The) 5.805% 5/1/2050  | 74 | 74 |
| Boeing Co. (The) 6.858% 5/1/2054  | 126 | 144 |
| Boeing Co. (The) 7.008% 5/1/2064  | 10000 | 11464 |
| Burlington Northern Santa Fe, LLC 3.05% 2/15/2051  | 3538 | 2401 |
| Canadian National Railway Co. 4.375% 9/18/2034  | 12848 | 12702 |
| Canadian National Railway Co. 6.125% 11/1/2053  | 4393 | 4831 |
| Canadian Pacific Railway Co. 4.80% 3/30/2030  | 15836 | 16257 |
| Canadian Pacific Railway Co. 5.20% 3/30/2035  | 35056 | 36348 |

---

Capital Group Central Corporate Bond Fund<sub>8</sub>

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Industrials (continued)** | **Industrials (continued)** | **Industrials (continued)** |
| Canadian Pacific Railway Co. 3.00% 12/2/2041  | USD5,582 | $4221 |
| Canadian Pacific Railway Co. 3.10% 12/2/2051  | 17398 | 11755 |
| Carrier Global Corp. 5.90% 3/15/2034  | 2824 | 3052 |
| CSX Corp. 3.80% 3/1/2028  | 19416 | 19397 |
| CSX Corp. 4.25% 3/15/2029  | 12943 | 13078 |
| CSX Corp. 2.40% 2/15/2030  | 5892 | 5541 |
| CSX Corp. 4.10% 11/15/2032  | 10489 | 10360 |
| CSX Corp. 5.20% 11/15/2033  | 7415 | 7776 |
| CSX Corp. 4.30% 3/1/2048  | 10688 | 9098 |
| CSX Corp. 4.50% 3/15/2049  | 6729 | 5883 |
| CSX Corp. 2.50% 5/15/2051  | 12071 | 7314 |
| General Electric Co. 4.30% 7/29/2030  | 6363 | 6437 |
| General Electric Co. 4.90% 1/29/2036  | 36522 | 37490 |
| L3Harris Technologies, Inc. 5.40% 7/31/2033  | 5978 | 6285 |
| Norfolk Southern Corp. 2.55% 11/1/2029  | 3485 | 3298 |
| Norfolk Southern Corp. 5.05% 8/1/2030  | 14320 | 14886 |
| Norfolk Southern Corp. 4.45% 3/1/2033  | 10064 | 10091 |
| Norfolk Southern Corp. 5.10% 5/1/2035  | 10930 | 11250 |
| Norfolk Southern Corp. 3.40% 11/1/2049  | 2406 | 1740 |
| Norfolk Southern Corp. 4.55% 6/1/2053  | 2237 | 1937 |
| Norfolk Southern Corp. 5.35% 8/1/2054  | 15816 | 15434 |
| Northrop Grumman Corp. 4.70% 3/15/2033  | 15000 | 15246 |
| Northrop Grumman Corp. 4.90% 6/1/2034  | 2790 | 2847 |
| Northrop Grumman Corp. 4.95% 3/15/2053  | 6083 | 5597 |
| RTX Corp. 4.125% 11/16/2028  | 4205 | 4220 |
| RTX Corp. 1.90% 9/1/2031  | 8014 | 7056 |
| RTX Corp. 6.10% 3/15/2034  | 10914 | 12047 |
| RTX Corp. 2.82% 9/1/2051  | 6000 | 3841 |
| RTX Corp. 3.03% 3/15/2052  | 6000 | 3987 |
| RTX Corp. 6.40% 3/15/2054  | 5816 | 6520 |
| Siemens Funding BV 5.20% 5/28/2035 <sup>(b)</sup>  | 15000 | 15650 |
| Siemens Funding BV 5.80% 5/28/2055 <sup>(b)</sup>  | 15653 | 16688 |
| Siemens Funding BV 5.90% 5/28/2065 <sup>(b)</sup>  | 5557 | 5959 |
| Union Pacific Corp. 2.40% 2/5/2030  | 750 | 704 |
| Union Pacific Corp. 2.80% 2/14/2032  | 31546 | 29063 |
| Union Pacific Corp. 2.891% 4/6/2036  | 27376 | 23305 |
| Union Pacific Corp. 3.375% 2/14/2042  | 4360 | 3504 |
| Union Pacific Corp. 4.30% 3/1/2049  | 832 | 704 |
| Union Pacific Corp. 3.25% 2/5/2050  | 106 | 75 |
| Union Pacific Corp. 3.50% 2/14/2053  | 6721 | 4891 |
| Union Pacific Corp. 5.60% 12/1/2054  | 10628 | 10813 |
| Union Pacific Corp. 3.839% 3/20/2060  | 3297 | 2448 |
| Union Pacific Corp. 3.75% 2/5/2070  | 1832 | 1271 |
| Verisk Analytics, Inc. 4.50% 8/15/2030  | 5807 | 5857 |
| Verisk Analytics, Inc. 5.125% 2/15/2036  | 6781 | 6882 |
|  |  | 714103 |
| **Information technology 6.28%** | **Information technology 6.28%** | **Information technology 6.28%** |
| Amphenol Corp. 4.125% 11/15/2030  | 7000 | 6988 |
| Amphenol Corp. 4.40% 2/15/2033  | 27928 | 27816 |
| Amphenol Corp. 4.625% 2/15/2036  | 30420 | 30145 |
| Amphenol Corp. 5.30% 11/15/2055  | 18154 | 17698 |
| Analog Devices, Inc. 2.10% 10/1/2031  | 6258 | 5570 |
| Analog Devices, Inc. 2.80% 10/1/2041  | 4230 | 3160 |
| Analog Devices, Inc. 2.95% 10/1/2051  | 7728 | 5107 |
| Analog Devices, Inc. 5.30% 4/1/2054  | 10992 | 10847 |
| Broadcom, Inc. 4.75% 4/15/2029  | 3562 | 3639 |
| Broadcom, Inc. 4.15% 11/15/2030  | 7897 | 7895 |
| Broadcom, Inc. 3.469% 4/15/2034  | 27412 | 25297 |
| Broadcom, Inc. 4.80% 10/15/2034  | 2079 | 2109 |
| Broadcom, Inc. 5.20% 7/15/2035  | 22220 | 23147 |
| Broadcom, Inc. 4.80% 2/15/2036  | 26995 | 27069 |
| Broadcom, Inc. 4.926% 5/15/2037 <sup>(b)</sup>  | 20881 | 20996 |
| Cisco Systems, Inc. 5.05% 2/26/2034  | 6554 | 6804 |
| Cisco Systems, Inc. 5.10% 2/24/2035  | 21908 | 22756 |

---

---

| | |
|:---|:---|
| **9** | Capital Group Central Corporate Bond Fund |

---

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Information technology (continued)** | **Information technology (continued)** | **Information technology (continued)** |
| Cisco Systems, Inc. 5.30% 2/26/2054  | USD1,250 | $1226 |
| Intel Corp. 3.05% 8/12/2051  | 72386 | 45787 |
| Intel Corp. 5.60% 2/21/2054  | 16304 | 15557 |
| Intel Corp. 3.10% 2/15/2060  | 18775 | 11063 |
| Microchip Technology, Inc. 4.90% 3/15/2028  | 2660 | 2699 |
| Microchip Technology, Inc. 5.05% 3/15/2029  | 18732 | 19131 |
| Microchip Technology, Inc. 5.05% 2/15/2030  | 17244 | 17625 |
| Oracle Corp. 4.45% 9/26/2030  | 13775 | 13579 |
| Oracle Corp. 5.50% 8/3/2035  | 64456 | 64614 |
| Oracle Corp. 5.20% 9/26/2035  | 21546 | 21124 |
| Oracle Corp. 5.875% 9/26/2045  | 3955 | 3731 |
| Oracle Corp. 6.00% 8/3/2055  | 26578 | 24713 |
| Oracle Corp. 5.95% 9/26/2055  | 31419 | 29464 |
| Oracle Corp. 6.10% 9/26/2065  | 14886 | 13875 |
| Roper Technologies, Inc. 4.25% 9/15/2028  | 13000 | 13063 |
| Roper Technologies, Inc. 4.45% 9/15/2030  | 5000 | 5031 |
| Roper Technologies, Inc. 5.10% 9/15/2035  | 15583 | 15823 |
| ServiceNow, Inc. 1.40% 9/1/2030  | 8990 | 7934 |
| Synopsys, Inc. 4.85% 4/1/2030  | 25765 | 26328 |
| Synopsys, Inc. 5.15% 4/1/2035  | 23239 | 23766 |
| Synopsys, Inc. 5.70% 4/1/2055  | 55747 | 55932 |
| Texas Instruments, Inc. 5.10% 5/23/2035  | 10550 | 10936 |
| Texas Instruments, Inc. 5.15% 2/8/2054  | 7213 | 6946 |
|  |  | 696990 |
| **Consumer staples 5.38%** | **Consumer staples 5.38%** | **Consumer staples 5.38%** |
| Anheuser-Busch InBev Worldwide, Inc. 3.50% 6/1/2030  | 7500 | 7349 |
| Anheuser-Busch InBev Worldwide, Inc. 5.00% 6/15/2034  | 5311 | 5529 |
| Anheuser-Busch InBev Worldwide, Inc. 5.55% 1/23/2049  | 2500 | 2546 |
| BAT Capital Corp. 3.215% 9/6/2026  | 11050 | 10978 |
| BAT Capital Corp. 4.70% 4/2/2027  | 6420 | 6460 |
| BAT Capital Corp. 3.557% 8/15/2027  | 47755 | 47305 |
| BAT Capital Corp. 3.462% 9/6/2029  | 2000 | 1946 |
| BAT Capital Corp. 4.906% 4/2/2030  | 2500 | 2562 |
| BAT Capital Corp. 5.35% 8/15/2032  | 2900 | 3026 |
| BAT Capital Corp. 4.625% 3/22/2033  | 9114 | 9101 |
| BAT Capital Corp. 6.421% 8/2/2033  | 15511 | 17214 |
| BAT Capital Corp. 6.00% 2/20/2034  | 6964 | 7498 |
| BAT Capital Corp. 5.625% 8/15/2035  | 18917 | 19843 |
| BAT Capital Corp. 4.54% 8/15/2047  | 111 | 94 |
| BAT Capital Corp. 4.758% 9/6/2049  | 2283 | 1963 |
| BAT Capital Corp. 5.65% 3/16/2052  | 3687 | 3549 |
| BAT Capital Corp. 6.25% 8/15/2055  | 14796 | 15582 |
| Coca-Cola Co. 5.30% 5/13/2054  | 6666 | 6670 |
| Coca-Cola Co. 5.20% 1/14/2055  | 6363 | 6280 |
| Constellation Brands, Inc. 3.60% 2/15/2028  | 2813 | 2787 |
| Constellation Brands, Inc. 2.875% 5/1/2030  | 1688 | 1591 |
| Constellation Brands, Inc. 4.80% 5/1/2030  | 3274 | 3335 |
| Constellation Brands, Inc. 2.25% 8/1/2031  | 19412 | 17219 |
| Constellation Brands, Inc. 4.75% 5/9/2032  | 24906 | 25198 |
| Coty, Inc. 5.60% 1/15/2031 <sup>(b)</sup>  | 7650 | 7707 |
| Imperial Brands Finance PLC 5.625% 7/1/2035 <sup>(b)</sup>  | 19473 | 20082 |
| Imperial Brands Finance PLC 6.375% 7/1/2055 <sup>(b)</sup>  | 12021 | 12473 |
| Keurig Dr Pepper, Inc. 5.15% 5/15/2035  | 7130 | 7176 |
| Kroger Co. 5.00% 9/15/2034  | 3711 | 3772 |
| Kroger Co. 5.50% 9/15/2054  | 9790 | 9554 |
| Mars, Inc. 4.80% 3/1/2030 <sup>(b)</sup>  | 8000 | 8198 |
| Mars, Inc. 5.00% 3/1/2032 <sup>(b)</sup>  | 34555 | 35730 |
| Mars, Inc. 5.20% 3/1/2035 <sup>(b)</sup>  | 31449 | 32549 |
| Mars, Inc. 5.70% 5/1/2055 <sup>(b)</sup>  | 54924 | 56026 |
| Mars, Inc. 5.80% 5/1/2065 <sup>(b)</sup>  | 3072 | 3157 |
| Mondelez International, Inc. 5.125% 5/6/2035  | 4022 | 4135 |
| Philip Morris International, Inc. 4.875% 2/13/2026  | 6250 | 6256 |
| Philip Morris International, Inc. 3.375% 8/15/2029  | 2363 | 2308 |
| Philip Morris International, Inc. 2.10% 5/1/2030  | 9300 | 8530 |

---

Capital Group Central Corporate Bond Fund<sub>10</sub>

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Consumer staples (continued)** | **Consumer staples (continued)** | **Consumer staples (continued)** |
| Philip Morris International, Inc. 4.00% 10/29/2030  | USD13,573 | $13454 |
| Philip Morris International, Inc. 1.75% 11/1/2030  | 12193 | 10875 |
| Philip Morris International, Inc. 4.75% 11/1/2031  | 12576 | 12862 |
| Philip Morris International, Inc. 5.75% 11/17/2032  | 7503 | 8064 |
| Philip Morris International, Inc. 5.375% 2/15/2033  | 7900 | 8283 |
| Philip Morris International, Inc. 5.625% 9/7/2033  | 16910 | 18034 |
| Philip Morris International, Inc. 5.25% 2/13/2034  | 8055 | 8367 |
| Philip Morris International, Inc. 4.90% 11/1/2034  | 26270 | 26652 |
| Philip Morris International, Inc. 4.875% 4/30/2035  | 24630 | 24872 |
| Philip Morris International, Inc. 4.625% 10/29/2035  | 4362 | 4296 |
| Philip Morris International, Inc. 4.125% 3/4/2043  | 3577 | 3086 |
| Reynolds American, Inc. 5.85% 8/15/2045  | 15050 | 15016 |
|  |  | 597139 |
| **Consumer discretionary 4.51%** | **Consumer discretionary 4.51%** | **Consumer discretionary 4.51%** |
| Amazon.com, Inc. 4.10% 11/20/2030  | 8330 | 8372 |
| Amazon.com, Inc. 4.35% 3/20/2033  | 13489 | 13587 |
| Amazon.com, Inc. 4.65% 11/20/2035  | 36383 | 36722 |
| Amazon.com, Inc. 5.45% 11/20/2055  | 11728 | 11837 |
| Ford Motor Co. 3.25% 2/12/2032  | 1576 | 1385 |
| Ford Motor Credit Co., LLC 6.95% 3/6/2026  | 1042 | 1047 |
| Ford Motor Credit Co., LLC 6.95% 6/10/2026  | 802 | 810 |
| Ford Motor Credit Co., LLC 4.271% 1/9/2027  | 200 | 199 |
| Ford Motor Credit Co., LLC 5.85% 5/17/2027  | 2800 | 2839 |
| Ford Motor Credit Co., LLC 4.95% 5/28/2027  | 2435 | 2441 |
| Ford Motor Credit Co., LLC 4.125% 8/17/2027  | 641 | 635 |
| Ford Motor Credit Co., LLC 3.815% 11/2/2027  | 220 | 216 |
| Ford Motor Credit Co., LLC 7.35% 11/4/2027  | 1159 | 1210 |
| Ford Motor Credit Co., LLC 5.918% 3/20/2028  | 2900 | 2965 |
| Ford Motor Credit Co., LLC 6.80% 5/12/2028  | 3304 | 3442 |
| Ford Motor Credit Co., LLC 6.798% 11/7/2028  | 8322 | 8715 |
| Ford Motor Credit Co., LLC 2.90% 2/10/2029  | 810 | 758 |
| Ford Motor Credit Co., LLC 5.875% 11/7/2029  | 17600 | 18011 |
| Ford Motor Credit Co., LLC 7.35% 3/6/2030  | 240 | 258 |
| Ford Motor Credit Co., LLC 7.20% 6/10/2030  | 935 | 1004 |
| Ford Motor Credit Co., LLC 5.73% 9/5/2030  | 29074 | 29600 |
| Ford Motor Credit Co., LLC 4.00% 11/13/2030  | 500 | 471 |
| Ford Motor Credit Co., LLC 6.532% 3/19/2032  | 9400 | 9847 |
| Ford Motor Credit Co., LLC 6.125% 3/8/2034  | 3397 | 3457 |
| Ford Motor Credit Co., LLC 6.50% 2/7/2035  | 21720 | 22614 |
| Ford Motor Credit Co., LLC 5.869% 10/31/2035  | 10870 | 10808 |
| General Motors Financial Co., Inc. 5.35% 1/7/2030  | 12300 | 12699 |
| General Motors Financial Co., Inc. 5.45% 9/6/2034  | 3114 | 3176 |
| General Motors Financial Co., Inc. 5.90% 1/7/2035  | 6217 | 6509 |
| General Motors Financial Co., Inc. 6.15% 7/15/2035  | 4370 | 4643 |
| Home Depot, Inc. 2.50% 4/15/2027  | 3400 | 3343 |
| Home Depot, Inc. 2.95% 6/15/2029  | 5000 | 4845 |
| Home Depot, Inc. 1.375% 3/15/2031  | 757 | 658 |
| Home Depot, Inc. 4.85% 6/25/2031  | 10263 | 10644 |
| Home Depot, Inc. 4.95% 6/25/2034  | 32524 | 33484 |
| Home Depot, Inc. 4.65% 9/15/2035  | 17059 | 17064 |
| Home Depot, Inc. 3.125% 12/15/2049  | 1102 | 767 |
| Home Depot, Inc. 5.30% 6/25/2054  | 39454 | 38602 |
| Hyundai Capital America 4.875% 6/23/2027 <sup>(b)</sup>  | 8555 | 8646 |
| Hyundai Capital America 2.375% 10/15/2027 <sup>(b)</sup>  | 1745 | 1689 |
| Hyundai Capital America 4.55% 9/26/2029 <sup>(b)</sup>  | 16992 | 17085 |
| Hyundai Capital America 5.10% 6/24/2030 <sup>(b)</sup>  | 10621 | 10895 |
| Hyundai Capital America 4.50% 9/18/2030 <sup>(b)</sup>  | 15700 | 15729 |
| Marriott International, Inc. 5.35% 3/15/2035  | 12285 | 12726 |
| McDonald's Corp. 5.00% 5/17/2029  | 1524 | 1572 |
| McDonald's Corp. 4.95% 3/3/2035  | 3991 | 4081 |
| McDonald's Corp. 4.60% 5/26/2045  | 1962 | 1768 |
| McDonald's Corp. 4.45% 3/1/2047  | 1416 | 1232 |
| McDonald's Corp. 3.625% 9/1/2049  | 1117 | 838 |
| Morongo Band of Mission Indians (The) 7.00% 10/1/2039 <sup>(b)</sup>  | 5000 | 5460 |

---

---

| | |
|:---|:---|
| **11** | Capital Group Central Corporate Bond Fund |

---

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Consumer discretionary (continued)** | **Consumer discretionary (continued)** | **Consumer discretionary (continued)** |
| Royal Caribbean Cruises, Ltd. 5.375% 1/15/2036  | USD26,214 | $26510 |
| Starbucks Corp. 4.85% 2/8/2027  | 13970 | 14092 |
| Starbucks Corp. 5.00% 2/15/2034  | 5056 | 5188 |
| Starbucks Corp. 5.40% 5/15/2035  | 16620 | 17389 |
| Toyota Motor Corp. 4.186% 6/30/2027  | 25803 | 25960 |
|  |  | 500544 |
| **Energy 2.00%** | **Energy 2.00%** | **Energy 2.00%** |
| Canadian Natural Resources, Ltd. 3.85% 6/1/2027  | 8661 | 8627 |
| Canadian Natural Resources, Ltd. 2.95% 7/15/2030  | 2690 | 2534 |
| Chevron Corp. 2.236% 5/11/2030  | 8314 | 7730 |
| Chevron Corp. 3.078% 5/11/2050  | 3879 | 2698 |
| Chevron USA, Inc. 4.405% 2/26/2027  | 36121 | 36441 |
| Chevron USA, Inc. 1.018% 8/12/2027  | 1644 | 1572 |
| Chevron USA, Inc. 3.25% 10/15/2029  | 4050 | 3967 |
| Chevron USA, Inc. 2.343% 8/12/2050  | 374 | 224 |
| ConocoPhillips Co. 4.70% 1/15/2030  | 11250 | 11500 |
| ConocoPhillips Co. 3.80% 3/15/2052  | 3099 | 2336 |
| ConocoPhillips Co. 5.30% 5/15/2053  | 5564 | 5310 |
| ConocoPhillips Co. 5.50% 1/15/2055  | 18973 | 18562 |
| Enterprise Products Operating, LLC 5.20% 1/15/2036  | 7936 | 8146 |
| EOG Resources, Inc. 4.40% 7/15/2028  | 3622 | 3667 |
| EOG Resources, Inc. 5.35% 1/15/2036  | 2110 | 2190 |
| EOG Resources, Inc. 5.65% 12/1/2054  | 3995 | 3999 |
| EOG Resources, Inc. 5.95% 7/15/2055  | 2580 | 2687 |
| Equinor ASA 3.70% 4/6/2050  | 2662 | 2077 |
| Exxon Mobil Corp. 2.61% 10/15/2030  | 1387 | 1302 |
| Exxon Mobil Corp. 3.452% 4/15/2051  | 27479 | 20216 |
| Petroleos Mexicanos 6.84% 1/23/2030  | 4000 | 4051 |
| Shell Finance US, Inc. 2.75% 4/6/2030  | 21750 | 20710 |
| Shell Finance US, Inc. 3.25% 4/6/2050  | 15167 | 10747 |
| Shell International Finance BV 3.00% 11/26/2051  | 2085 | 1394 |
| TotalEnergies Capital International SA 2.986% 6/29/2041  | 517 | 395 |
| TotalEnergies Capital International SA 3.127% 5/29/2050  | 9475 | 6497 |
| TotalEnergies Capital SA 5.488% 4/5/2054  | 6654 | 6573 |
| TotalEnergies Capital SA 5.275% 9/10/2054  | 26424 | 25451 |
|  |  | 221603 |
| **Materials 1.67%** | **Materials 1.67%** | **Materials 1.67%** |
| BHP Billiton Finance (USA), Ltd. 5.30% 2/21/2035  | 5000 | 5207 |
| BHP Billiton Finance (USA), Ltd. 5.75% 9/5/2055  | 23506 | 24526 |
| Dow Chemical Co. (The) 4.80% 1/15/2031  | 10110 | 10089 |
| Dow Chemical Co. (The) 5.15% 2/15/2034  | 7156 | 7160 |
| Dow Chemical Co. (The) 5.35% 3/15/2035  | 2167 | 2164 |
| Dow Chemical Co. (The) 5.65% 3/15/2036  | 5521 | 5549 |
| Dow Chemical Co. (The) 4.80% 5/15/2049  | 21763 | 17597 |
| Dow Chemical Co. (The) 3.60% 11/15/2050  | 1874 | 1250 |
| Dow Chemical Co. (The) 5.60% 2/15/2054  | 13136 | 11751 |
| Dow Chemical Co. (The) 5.95% 3/15/2055  | 4675 | 4373 |
| LYB International Finance III, LLC 5.125% 1/15/2031  | 1604 | 1610 |
| LYB International Finance III, LLC 6.15% 5/15/2035  | 245 | 254 |
| LYB International Finance III, LLC 5.875% 1/15/2036  | 11959 | 12006 |
| Minera Mexico, SA de CV, 5.625% 2/12/2032 <sup>(b)</sup>  | 9000 | 9287 |
| Rio Tinto Finance (USA) PLC 5.25% 3/14/2035  | 15687 | 16282 |
| Sherwin-Williams Co. 4.50% 8/15/2030  | 9000 | 9094 |
| Sherwin-Williams Co. 2.20% 3/15/2032  | 6865 | 6058 |
| Sherwin-Williams Co. 5.15% 8/15/2035  | 20993 | 21524 |
| Sherwin-Williams Co. 2.90% 3/15/2052  | 3515 | 2211 |
| Vale Overseas, Ltd. 6.40% 6/28/2054  | 7784 | 8033 |

---

Capital Group Central Corporate Bond Fund<sub>12</sub>

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** | **Corporate bonds, notes & loans (continued)** |
| **Materials (continued)** | **Materials (continued)** | **Materials (continued)** |
| Vale Overseas, Ltd. 6.00% 2/25/2056 (5-year UST Yield Curve Rate T Note Constant Maturity + 2.431% on <br> 2/25/2031) <sup>(a)(b)</sup>  | USD2,815 | $2805 |
| Westlake Corp. 5.55% 11/15/2035  | 4461 | 4492 |
| Westlake Corp. 6.375% 11/15/2055  | 2000 | 1999 |
|  |  | 185321 |
| **Real estate 1.52%** | **Real estate 1.52%** | **Real estate 1.52%** |
| Alexandria Real Estate Equities, Inc. 4.30% 1/15/2026  | 1050 | 1050 |
| Boston Properties, LP 2.55% 4/1/2032  | 1489 | 1300 |
| Boston Properties, LP 2.45% 10/1/2033  | 2723 | 2258 |
| Boston Properties, LP 6.50% 1/15/2034  | 8579 | 9282 |
| Boston Properties, LP 5.75% 1/15/2035  | 50549 | 52084 |
| COPT Defense Properties, LP 2.25% 3/15/2026  | 3191 | 3171 |
| Crown Castle, Inc. 5.00% 1/11/2028  | 8308 | 8435 |
| ERP Operating, LP 4.65% 9/15/2034  | 5923 | 5909 |
| Ladder Capital Finance Holdings LLLP 5.50% 8/1/2030  | 11170 | 11430 |
| Piedmont Operating Partnership, LP 5.625% 1/15/2033  | 5172 | 5213 |
| Prologis, LP 4.75% 6/15/2033  | 5665 | 5765 |
| Prologis, LP 5.125% 1/15/2034  | 10133 | 10474 |
| Prologis, LP 5.00% 3/15/2034  | 8500 | 8714 |
| Prologis, LP 5.00% 1/31/2035  | 2656 | 2707 |
| Prologis, LP 5.25% 6/15/2053  | 2258 | 2183 |
| Prologis, LP 5.25% 3/15/2054  | 464 | 449 |
| Simon Property Group, LP 4.375% 10/1/2030  | 15000 | 15128 |
| Simon Property Group, LP 5.125% 10/1/2035  | 22358 | 22818 |
|  |  | 168370 |
| **Total corporate bonds, notes & loans** | **Total corporate bonds, notes & loans** | 9100872 |
| **U.S. Treasury bonds & notes 6.90%** | **U.S. Treasury bonds & notes 6.90%** | **U.S. Treasury bonds & notes 6.90%** |
| **U.S. Treasury 6.90%** | **U.S. Treasury 6.90%** | **U.S. Treasury 6.90%** |
| U.S. Treasury 3.50% 10/31/2027  | 19236 | 19234 |
| U.S. Treasury 4.125% 11/15/2027  | 3406 | 3445 |
| U.S. Treasury 3.50% 11/15/2028  | 78239 | 78254 |
| U.S. Treasury 4.00% 7/31/2029  | 2502 | 2541 |
| U.S. Treasury 3.625% 10/31/2030 <sup>(c)</sup>  | 230063 | 230315 |
| U.S. Treasury 3.75% 10/31/2032 <sup>(c)</sup>  | 18698 | 18660 |
| U.S. Treasury 4.25% 5/15/2035  | 1000 | 1021 |
| U.S. Treasury 4.00% 11/15/2035  | 155514 | 155271 |
| U.S. Treasury 4.625% 11/15/2045  | 85035 | 84969 |
| U.S. Treasury 4.75% 8/15/2055  | 169460 | 171605 |
|  |  | 765315 |
| **Asset-backed obligations 0.86%** | **Asset-backed obligations 0.86%** | **Asset-backed obligations 0.86%** |
| Castlelake Aircraft Securitization Trust, Series 2021-1, Class A, 2.868% 5/11/2037 <sup>(b)(d)</sup>  | 9463 | 8972 |
| CF Hippolyta, LLC, Series 2020-1, Class A1, 1.69% 7/15/2060 <sup>(b)(d)</sup>  | 9183 | 7893 |
| CF Hippolyta, LLC, Series 2020-1, Class A2, 1.99% 7/15/2060 <sup>(b)(d)</sup>  | 693 | 585 |
| CF Hippolyta, LLC, Series 2021-1, Class A1, 1.53% 3/15/2061 <sup>(b)(d)</sup>  | 6564 | 5393 |
| New Economy Assets Phase 1 Issuer, LLC, Series 2021-1, Class A1, 1.91% 10/20/2061 <sup>(b)(d)</sup>  | 85298 | 72535 |
|  |  | 95378 |
| **Bonds & notes of governments & government agencies outside the U.S. 0.40%** | **Bonds & notes of governments & government agencies outside the U.S. 0.40%** | **Bonds & notes of governments & government agencies outside the U.S. 0.40%** |
| Eagle Funding LuxCo SARL 5.50% 8/17/2030 <sup>(b)</sup>  | 28850 | 29324 |
| United Mexican States 5.375% 3/22/2033  | 6875 | 6878 |
| United Mexican States 6.625% 1/29/2038  | 2785 | 2936 |
| United Mexican States 7.375% 5/13/2055  | 5295 | 5817 |
|  |  | 44955 |

---

---

| | |
|:---|:---|
| **13** | Capital Group Central Corporate Bond Fund |

---

------

---

| | | |
|:---|:---|:---|
| Bonds, notes & other debt instruments (continued) | Principal amount<br> (000)<br>| Value<br> (000)<br>|
| **Municipals 0.05%** | **Municipals 0.05%** | **Municipals 0.05%** |
| **Ohio 0.05%** | **Ohio 0.05%** | **Ohio 0.05%** |
| Cleveland-Cuyahoga Port Auth., Federal Lease Rev. Bonds (VA Cleveland Health Care Center Project), Series <br> 2021, 4.425% 5/1/2031  | USD5,655 | $5150 |
| **Total bonds, notes & other debt instruments** (cost: $9,970,170,000) | **Total bonds, notes & other debt instruments** (cost: $9,970,170,000) | 10011670 |
| Short-term securities 9.80% | Shares |  |
| **Money market investments 9.80%** | **Money market investments 9.80%** | **Money market investments 9.80%** |
| Capital Group Central Cash Fund 3.94% <sup>(e)(f)</sup>  | 10874103 | 1087301 |
| **Total short-term securities** (cost: $1,087,352,000) | **Total short-term securities** (cost: $1,087,352,000) | 1087301 |
| **Total investment securities 100.04%** (cost: $11,057,522,000) | **Total investment securities 100.04%** (cost: $11,057,522,000) | 11098971 |
| Other assets less liabilities (0.04%) |  | (4853)<br>|
| **Net assets 100.00%** |  | $11094118 |

---

**Futures contracts**

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Contracts | Type | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Number of <br>contracts<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Expiration <br>date<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Notional <br>amount <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(000)<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Value and <br>unrealized <br>appreciation <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(depreciation) <br>at 11/30/2025 <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(000)<br>|
| 2 Year U.S. Treasury Note Futures | Long | 3961 | 4/6/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; USD827,292 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $97 |
| 5 Year U.S. Treasury Note Futures | Long | 7637 | 4/6/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 838280 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1243 |
| 10 Year U.S. Treasury Note Futures | Long | 631 | 3/31/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 71520 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (25)<br>|
| 10 Year Ultra U.S. Treasury Note Futures | Short | 12340 | 3/31/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1433947)<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (10046)<br>|
| 20 Year U.S. Treasury Bond Futures | Long | 8081 | 3/31/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 949013 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2512 |
| 30 Year Ultra U.S. Treasury Bond Futures | Short | 2398 | 3/31/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (290008)<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1521)<br>|
|  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(7740)<br>|

---

**Swap contracts**

------

**Credit default swaps** 

**Centrally cleared credit default swaps on credit indices — buy protection** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Reference <br>index<br>| &nbsp;&nbsp;&nbsp;&nbsp; Financing <br>rate paid<br>| &nbsp;&nbsp;&nbsp;&nbsp; Payment <br>frequency<br>| &nbsp;&nbsp;&nbsp;&nbsp; Expiration <br>date<br>| &nbsp;&nbsp;&nbsp;&nbsp; Notional <br>amount <br>&nbsp;&nbsp;&nbsp;&nbsp;(000)<br>| &nbsp;&nbsp;&nbsp;&nbsp; Value at <br>11/30/2025 <br>&nbsp;&nbsp;&nbsp;&nbsp;(000)<br>| &nbsp;&nbsp;&nbsp;&nbsp; Upfront <br>premium <br>paid <br>&nbsp;&nbsp;&nbsp;&nbsp;(received) <br>&nbsp;&nbsp;&nbsp;&nbsp;(000)<br>| &nbsp;&nbsp;&nbsp;&nbsp; Unrealized <br>appreciation <br>&nbsp;&nbsp;&nbsp;&nbsp;(depreciation) <br>at 11/30/2025 <br>&nbsp;&nbsp;&nbsp;&nbsp;(000)<br>|
| CDX.NA.IG.45 | 1.00% | Quarterly | &nbsp;&nbsp;&nbsp;&nbsp; 12/20/2030 | USD971,244 | &nbsp;&nbsp;&nbsp;&nbsp; $(21847)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(21651)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(196)<br>|

---

**Investments in affiliates** <sup>(f)</sup>

------

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Value at <br>6/1/2025 <br>(000)<br>| Additions <br>(000)<br>| Reductions <br>(000)<br>| Net <br>realized <br>gain (loss) <br>(000)<br>| Net <br>unrealized <br>appreciation <br>(depreciation) <br>(000)<br>| Value at <br>11/30/2025 <br>(000)<br>| Dividend <br>or interest <br>income <br>(000)<br>|
| **Short-term securities 9.80%** |  |  |  |  |  |  |  |
| **Money market investments 9.80%** |  |  |  |  |  |  |  |
| Capital Group Central Cash Fund 3.94% <sup>(e)</sup>  | $522980 | &nbsp;&nbsp; $2607081 | &nbsp;&nbsp; $2042722 | &nbsp;&nbsp; $36 | &nbsp;&nbsp; $(74)<br>| &nbsp;&nbsp; $1087301 | &nbsp;&nbsp; $18503 |

---

Capital Group Central Corporate Bond Fund<sub>14</sub>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> Step bond; coupon rate may change at a later date.

<sup>(b)</sup> Acquired in a transaction exempt from registration under Rule 144A or, for commercial paper, Section 4(a)(2) of the Securities Act of 1933. May be resold in the U.S. in transactions exempt from registration, normally to qualified institutional buyers. The total value of all such securities was $893,975,000, which represented 8.06% of the net assets of the fund. 

<sup>(c)</sup> All or a portion of this security was pledged as collateral. The total value of pledged collateral was $30,363,000, which represented 0.27% of the net assets of the fund. 

<sup>(d)</sup> Principal payments may be made periodically. Therefore, the effective maturity date may be earlier than the stated maturity date.

<sup>(e)</sup> Rate represents the seven-day yield at 11/30/2025.

<sup>(f)</sup> Affiliate of the fund or part of the same "group of investment companies" as the fund, as defined under the Investment Company Act of 1940, as amended.

---

| |
|:---|
| **Key to abbreviation(s)** |
| Auth. = Authority |
| CME = CME Group |
| DAC = Designated Activity Company |
| ICE = Intercontinental Exchange, Inc. |
| Rev. = Revenue |
| SOFR = Secured Overnight Financing Rate |
| USD = U.S. dollars |
| UST = U.S. Treasury |

---

Refer to the notes to financial statements.

---

| | |
|:---|:---|
| **15** | Capital Group Central Corporate Bond Fund |

---

------

Financial statements

**Statement of assets and liabilities** at November 30, 2025unaudited

------

(dollars in thousands)

---

| | | |
|:---|:---|:---|
| **Assets:** |  |  |
| Investment securities, at value: |  |  |
| Unaffiliated issuers (cost: $9,970,170) | $10011670 |  |
| Affiliated issuers (cost: $1,087,352) | 1087301 | $11098971 |
| Cash |  | 1594 |
| Receivables for: |  |  |
| Dividends and interest | 112506 |  |
| Variation margin on futures contracts | 4065 | 116571<br>|
|  |  | 11217136 |
| **Liabilities:** |  |  |
| Payables for: |  |  |
| Purchases of investments | 117958 |  |
| Trustees' deferred compensation | 100 |  |
| Variation margin on futures contracts | 4615 |  |
| Variation margin on centrally cleared swap contracts | 341 |  |
| Other | 4 | 123018<br>|
| **Net assets at November 30, 2025** |  | $11094118 |
| **Net assets consist of:** |  |  |
| Capital paid in on shares of beneficial interest |  | $13247586 |
| Total distributable earnings (accumulated loss) |  | (2153468) <br>|
| **Net assets at November 30, 2025** |  | $11094118 |

---

------

(dollars and shares in thousands, except per-share amounts)

**Shares of beneficial interest issued and outstanding (no stated par value) —**

**unlimited shares authorized (1,294,867 total shares outstanding)** 

---

| | | | |
|:---|:---|:---|:---|
|  | Net assets | Shares <br>outstanding<br>| Net asset value <br>per share<br>|
| Class M | $11094118 | 1294867 | $8.57 |

---

Refer to the notes to financial statements.

---

| | |
|:---|:---|
| Capital Group Central Corporate Bond Fund | **16** |

---

------

Financial statements (continued)

**Statement of operations** for the six months ended November 30, 2025unaudited

------

(dollars in thousands)

---

| | | |
|:---|:---|:---|
| **Investment income:** |  |  |
| Income: |  |  |
| Interest from unaffiliated issuers | $242608 |  |
| Dividends from affiliated issuers | 18503 | $261111 |
| Fees and expenses\*: |  |  |
| Reports to shareholders | 4 |  |
| Registration statement and prospectus | 35 |  |
| Trustees' compensation | 33 |  |
| Auditing and legal | 94 |  |
| Custodian | 37 |  |
| Other | 2 | 205<br>|
| Net investment income |  | 260906<br>|
| **Net realized gain (loss) and unrealized appreciation (depreciation):** |  |  |
| Net realized gain (loss) on: |  |  |
| Investments: |  |  |
| Unaffiliated issuers | 20725 |  |
| Affiliated issuers | 36 |  |
| Futures contracts | (7920)<br>|  |
| Swap contracts | (5803)<br>| 7038 |
| Net unrealized appreciation (depreciation) on: |  |  |
| Investments: |  |  |
| Unaffiliated issuers | 303225 |  |
| Affiliated issuers | (74)<br>|  |
| Futures contracts | (2364)<br>|  |
| Swap contracts | 79 | 300866<br>|
| Net realized gain (loss) and unrealized appreciation (depreciation) |  | 307904<br>|
| **Net increase (decrease) in net assets resulting from operations** |  | $568810 |

---

\*

Additional information related to class-specific fees and expenses is included in the notes to financial statements.

**Statements of changes in net assets**

------

(dollars in thousands)

---

| | | |
|:---|:---|:---|
|  | **Six months ended** <br>**November 30,**<br>| **Year ended** <br>**May 31,**<br>|
|  | **2025\*** | **2025** |
| **Operations:** |  |  |
| Net investment income | $260906 | $520957 |
| Net realized gain (loss) | 7038 | (207420)<br>|
| Net unrealized appreciation (depreciation) | 300866 | 298276 |
| Net increase (decrease) in net assets resulting from operations | 568810 | 611813 |
| **Distributions paid or accrued to shareholders** | (255240)<br>| (513755)<br>|
| **Net capital share transactions** | 187367 | (553896)<br>|
| **Total increase (decrease) in net assets**  | 500937 | (455838)<br>|
| **Net assets:** |  |  |
| Beginning of period | 10593181 | 11049019 |
| End of period | $11094118 | $10593181 |

---

\*

Unaudited.

Refer to the notes to financial statements.

---

| | |
|:---|:---|
| **17** | Capital Group Central Corporate Bond Fund |

---

------

Notes to financial statementsunaudited

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**1. Organization**

------

Capital Group Central Fund Series II (the "trust") is registered under the Investment Company Act of 1940, as amended (the "1940 Act"), as an open-end, diversified management investment company and has issued one series of shares, Capital Group Central Corporate Bond Fund ("the fund"). The fund seeks to provide maximum total return consistent with capital preservation and prudent risk management.

The fund serves as a corporate bond portfolio for Capital Group and other funds, investment vehicles and accounts advised by Capital Group affiliates, and is not available to the public.

**2. Significant accounting policies**

------

The fund is an investment company that applies the accounting and reporting guidance issued in Topic 946 by the U.S. Financial Accounting Standards Board ("FASB"). The fund's financial statements have been prepared to comply with U.S. generally accepted accounting principles ("U.S. GAAP"). These principles require the fund's investment adviser to make estimates and assumptions that affect reported amounts and disclosures. Actual results could differ from those estimates. Subsequent events, if any, have been evaluated through the date of issuance in the preparation of the financial statements. The fund follows the significant accounting policies described in this section, as well as the valuation policies described in the next section on valuation.

**Operating segments** — The fund represents a single operating segment as the operating results of the fund are monitored as a whole and its long-term asset allocation is determined in accordance with the terms of its prospectus, based on defined investment objectives that are executed by the fund's portfolio management team. A senior executive team comprised of the fund's Principal Executive Officer and Principal Financial Officer, serves as the fund's chief operating decision maker ("CODM"), who act in accordance with Board of Trustee reviews and approvals. The CODM uses financial information, such as changes in net assets from operations, changes in net assets from fund share transactions, and income and expense ratios, consistent with that presented within the accompanying financial statements and financial highlights to assess the fund's profits and losses and to make resource allocation decisions. Segment assets are reflected in the statement of assets and liabilities as net assets, which consists primarily of investment securities, at value, and significant segment expenses are listed in the accompanying statement of operations.

**Security transactions and related investment income** — Security transactions are recorded by the fund as of the date the trades are executed with brokers. Realized gains and losses from security transactions are determined based on the specific identified cost of the securities. In the event a security is purchased with a delayed payment date, the fund will segregate liquid assets sufficient to meet its payment obligations. Dividend income is recognized on the ex-dividend date and interest income is recognized on an accrual basis. Market discounts, premiums and original issue discounts on fixed-income securities are amortized daily over the expected life of the security.

**Distributions paid or accrued to shareholders** — Income dividends are declared daily after the determination of the fund's net investment income and are paid to shareholders monthly. Capital gain distributions are recorded on the ex-dividend date.

**New accounting pronouncements** — In December 2023, the FASB issued Accounting Standards Update 2023-09 ("the ASU"), Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances income tax disclosures, including disclosure of income taxes paid disaggregated by jurisdiction. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. Management is currently evaluating the ASU and its impact to the financial statements.

**3. Valuation**

------

Capital Research and Management Company ("CRMC"), the fund's investment adviser, values the fund's investments at fair value as defined by U.S. GAAP. The net asset value per share is calculated once daily as of the close of regular trading on the New York Stock Exchange, normally 4 p.m. New York time, each day the New York Stock Exchange is open.

**Methods and inputs** — The fund's investment adviser uses the following methods and inputs to establish the fair value of the fund's assets and liabilities. Use of particular methods and inputs may vary over time based on availability and relevance as market and economic conditions evolve.

---

| | |
|:---|:---|
| Capital Group Central Corporate Bond Fund | **18** |

---

------

Fixed-income securities, including short-term securities, are generally valued at evaluated prices obtained from third-party pricing vendors. Vendors value such securities based on one or more of the inputs described in the following table. The table provides examples of inputs that are commonly relevant for valuing particular classes of fixed-income securities in which the fund is authorized to invest. However, these classifications are not exclusive, and any of the inputs may be used to value any other class of fixed-income security.

---

| | |
|:---|:---|
| **Fixed-income class** | **Examples of standard inputs** |
| All | &nbsp;&nbsp; Benchmark yields, transactions, bids, offers, quotations from dealers and <br> trading systems, new issues, spreads and other relationships observed in <br> the markets among comparable securities; and proprietary pricing models <br> such as yield measures calculated using factors such as cash flows, financial <br> or collateral performance and other reference data (collectively referred to <br> as "standard inputs")<br>|
| Corporate bonds, notes & loans; convertible securities | Standard inputs and underlying equity of the issuer |
| Bonds & notes of governments & government agencies | Standard inputs and interest rate volatilities |
| Mortgage-backed; asset-backed obligations | &nbsp;&nbsp; Standard inputs and cash flows, prepayment information, default rates, <br> delinquency and loss assumptions, collateral characteristics, credit <br> enhancements and specific deal information<br>|
| Municipal securities | &nbsp;&nbsp; Standard inputs and, for certain distressed securities, cash flows or <br> liquidation values using a net present value calculation based on inputs that <br> include, but are not limited to, financial statements and debt contracts <br>|

---

The Capital Group Central Cash Fund ("CCF"), a fund within the Capital Group Central Fund Series ("Central Funds"), is valued based upon a floating net asset value, which fluctuates with changes in the value of CCF's portfolio securities. The underlying securities are valued based on the policies and procedures in CCF's statement of additional information. Exchange-traded futures are generally valued at the official settlement price on the exchange or market on which such instruments are traded, as of the close of business on the day the futures are being valued. Swaps are generally valued using evaluated prices obtained from third-party pricing vendors who calculate these values based on market inputs that may include the yields of the indices referenced in the instrument and the relevant curve, dealer quotes, default probabilities and recovery rates, and terms of the contract.

Securities and other assets for which representative market quotations are not readily available or are considered unreliable by the fund's investment adviser are fair valued as determined in good faith under fair valuation guidelines adopted by the fund's investment adviser and approved by the board of trustees as further described. The investment adviser follows fair valuation guidelines, consistent with U.S. Securities and Exchange Commission rules and guidance, to consider relevant principles and factors when making fair value determinations. The investment adviser considers relevant indications of value that are reasonably and timely available to it in determining the fair value to be assigned to a particular security, such as the type and cost of the security, restrictions on resale of the security, relevant financial or business developments of the issuer, actively traded similar or related securities, dealer or broker quotes, conversion or exchange rights on the security, related corporate actions, significant events occurring after the close of trading in the security, and changes in overall market conditions. In addition, the closing prices of equity securities that trade in markets outside U.S. time zones may be adjusted to reflect significant events that occur after the close of local trading but before the net asset value of each share class of the fund is determined. Fair valuations of investments that are not actively trading involve judgment and may differ materially from valuations that would have been used had greater market activity occurred.

**Processes and structure** — The fund's board of trustees has designated the fund's investment adviser to make fair value determinations, subject to board oversight. The investment adviser has established a Joint Fair Valuation Committee (the "Committee") to administer, implement and oversee the fair valuation process and to make fair value decisions. The Committee regularly reviews its own fair value decisions, as well as decisions made under its standing instructions to the investment adviser's valuation team. The Committee reviews changes in fair value measurements from period to period, pricing vendor information and market data, and may, as deemed appropriate, update the fair valuation guidelines to better reflect the results of back testing and address new or evolving issues. Pricing decisions, processes and controls over security valuation are also subject to additional internal reviews facilitated by the investment adviser's global risk management group. The Committee reports changes to the fair valuation guidelines to the board of trustees. The fund's board and audit committee also regularly review reports that describe fair value determinations and methods.

---

| | |
|:---|:---|
| **19** | Capital Group Central Corporate Bond Fund |

---

------

**Classifications** — The fund's investment adviser classifies the fund's assets and liabilities into three levels based on the inputs used to value the assets or liabilities. Level 1 values are based on quoted prices in active markets for identical securities. Level 2 values are based on significant observable market inputs, such as quoted prices for similar securities and quoted prices in inactive markets. Certain securities trading outside the U.S. may transfer between Level 1 and Level 2 due to valuation adjustments resulting from significant market movements following the close of local trading. Level 3 values are based on significant unobservable inputs that reflect the investment adviser's determination of assumptions that market participants might reasonably use in valuing the securities. The valuation levels are not necessarily an indication of the risk or liquidity associated with the underlying investment. For example, U.S. government securities are reflected as Level 2 because the inputs used to determine fair value may not always be quoted prices in an active market. The fund's valuation levels as of November 30, 2025, were as follows (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Investment securities** | **Investment securities** | **Investment securities** | **Investment securities** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Assets: |  |  |  |  |
| Bonds, notes & other debt instruments: |  |  |  |  |
| Corporate bonds, notes & loans | $— | $9100872 | $— | $9100872 |
| U.S. Treasury bonds & notes |  | 765315 |  | 765315 |
| Asset-backed obligations |  | 95378 |  | 95378 |
| Bonds & notes of governments & government agencies <br> outside the U.S.<br>|  | 44955 |  | 44955 |
| Municipals |  | 5150 |  | 5150 |
| Short-term securities  | 1087301 |  |  | 1087301 |
| Total | $1087301 | $10011670 | $— | $11098971 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Other investments\*** | **Other investments\*** | **Other investments\*** | **Other investments\*** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Assets: |  |  |  |  |
| Unrealized appreciation on futures contracts | $3852 | $— | $— | $3852 |
| Liabilities: |  |  |  |  |
| Unrealized depreciation on futures contracts | (11592)<br>|  |  | (11592)<br>|
| Unrealized depreciation on centrally cleared credit default swaps |  | (196)<br>|  | (196)<br>|
| Total  | $(7740)<br>| $(196)<br>| $— | $(7936)<br>|

---

\*

Futures contracts and credit default swaps are not included in the fund's investment portfolio.

**4. Risk factors**

------

Investing in the fund may involve certain risks including, but not limited to, those described below.

**Market conditions** — The prices of, and the income generated by, the securities held by the fund may decline – sometimes rapidly or unpredictably – due to various factors, including events or conditions affecting the general economy or particular industries or companies; overall market changes; local, regional or global political, social or economic instability; governmental, governmental agency or central bank responses to economic conditions; levels of public debt and deficits; changes in inflation rates; and currency exchange rate, interest rate and commodity price fluctuations.

---

| | |
|:---|:---|
| Capital Group Central Corporate Bond Fund | **20** |

---

------

Economies and financial markets throughout the world are highly interconnected. Economic, financial or political events, trading and tariff arrangements, wars, terrorism, cybersecurity events, natural disasters, public health emergencies (such as the spread of infectious disease), bank failures and other circumstances in one country or region, including actions taken by governmental or quasi-governmental authorities in response to any of the foregoing, could have impacts on global economies or markets. As a result, whether or not the fund invests in securities of issuers located in or with significant exposure to the countries affected, the value and liquidity of the fund's investments may be negatively affected by developments in other countries and regions.

**Issuer risks —** The prices of, and the income generated by, securities held by the fund may decline in response to various factors directly related to the issuers of such securities, including reduced demand for an issuer's goods or services, poor management performance, major litigation, investigations or other controversies related to the issuer, changes in the issuer's financial condition or credit rating, changes in government regulations affecting the issuer or its competitive environment and strategic initiatives such as mergers, acquisitions or dispositions and the market response to any such initiatives. An individual security may also be affected by factors relating to the industry or sector of the issuer or the securities markets as a whole, and conversely an industry or sector or the securities markets may be affected by a change in financial condition or other event affecting a single issuer. The fund's portfolio managers invest in issuers based on their level of investment conviction. At times, the fund may invest more significantly in a single issuer, which could increase the risk of loss arising from the factors described above.

**Investing in debt instruments —** The prices of, and the income generated by, bonds and other debt securities held by the fund may be affected by factors such as the interest rates, maturities and credit quality of these securities.

Rising interest rates will generally cause the prices of bonds and other debt securities to fall. Also, when interest rates rise, issuers of debt securities that may be prepaid at any time, such as mortgage- or other asset-backed securities, are less likely to refinance existing debt securities, causing the average life of such securities to extend. A general change in interest rates may cause investors to sell debt securities on a large scale, which could also adversely affect the price and liquidity of debt securities and could also result in increased redemptions from the fund. Falling interest rates may cause an issuer to redeem, call or refinance a debt security before its stated maturity, which may result in the fund having to reinvest the proceeds in lower yielding securities. Longer maturity debt securities generally have greater sensitivity to changes in interest rates and may be subject to greater price fluctuations than shorter maturity debt securities.

Bonds and other debt securities are also subject to credit risk, which is the possibility that the credit strength of an issuer or guarantor will weaken or be perceived to be weaker, and/or an issuer of a debt security will fail to make timely payments of principal or interest and the security will go into default. Changes in actual or perceived creditworthiness may occur quickly. A downgrade or default affecting any of the fund's securities could cause the value of the fund's shares to decrease. Lower quality debt securities generally have higher rates of interest and may be subject to greater price fluctuations than higher quality debt securities. Credit risk is gauged, in part, by the credit ratings of the debt securities in which the fund invests. However, ratings are only the opinions of the rating agencies issuing them and are not guarantees as to credit quality or an evaluation of market risk. The fund's investment adviser relies on its own credit analysts to research issuers and issues in assessing credit and default risks.

**Investing in securities backed by the U.S. government —** U.S. government securities are subject to market risk, interest rate risk and credit risk. Securities backed by the U.S. Treasury or the full faith and credit of the U.S. government are guaranteed only as to the timely payment of interest and principal when held to maturity. Accordingly, the current market values for these securities will fluctuate with changes in interest rates and the credit rating of the U.S. government. Notwithstanding that these securities are backed by the full faith and credit of the U.S. government, circumstances could arise that would prevent or delay the payment of interest or principal on these securities, which could adversely affect their value and cause the fund to suffer losses. Such an event could lead to significant disruptions in U.S. and global markets. Securities issued by U.S. government-sponsored entities and federal agencies and instrumentalities that are not backed by the full faith and credit of the U.S. government are neither issued nor guaranteed by the U.S. government.

---

| | |
|:---|:---|
| **21** | Capital Group Central Corporate Bond Fund |

---

------

**Investing in derivatives —** The use of derivatives involves a variety of risks, which may be different from, or greater than, the risks associated with investing in traditional securities, such as stocks and bonds. Changes in the value of a derivative may not correlate perfectly with, and may be more sensitive to market events than, the underlying asset, rate or index, and a derivative instrument may cause the fund to lose significantly more than its initial investment. Derivatives may be difficult to value, difficult for the fund to buy or sell at an opportune time or price and difficult, or even impossible, to terminate or otherwise offset. The fund's use of derivatives may result in losses to the fund, and investing in derivatives may reduce the fund's returns and increase the fund's price volatility. The fund's counterparty to a derivative transaction (including, if applicable, the fund's clearing broker, the derivatives exchange or the clearinghouse) may be unable or unwilling to honor its financial obligations in respect of the transaction. In certain cases, the fund may be hindered or delayed in exercising remedies against or closing out derivative instruments with a counterparty, which may result in additional losses. Derivatives are also subject to operational risk (such as documentation issues, settlement issues and systems failures) and legal risk (such as insufficient documentation, insufficient capacity or authority of a counterparty, and issues with the legality or enforceability of a contract).

**Liquidity risk** — Certain fund holdings may be or may become difficult or impossible to sell, particularly during times of market turmoil. Liquidity may be impacted by the lack of an active market for a holding, legal or contractual restrictions on resale, or the reduced number and capacity of market participants to make a market in such holding. Market prices for less liquid or illiquid holdings may be volatile or difficult to determine, and reduced liquidity may have an adverse impact on the market price of such holdings. Additionally, the sale of less liquid or illiquid holdings may involve substantial delays (including delays in settlement) and additional costs and the fund may be unable to sell such holdings when necessary to meet its liquidity needs or to try to limit losses, or may be forced to sell at a loss.

**Investing outside the U.S. —** Securities of issuers domiciled outside the U.S. or with significant operations or revenues outside the U.S., and securities tied economically to countries outside the U.S., may lose value because of adverse political, social, economic or market developments (including social instability, regional conflicts, terrorism and war) in the countries or regions in which the issuers are domiciled, operate or generate revenue or to which the securities are tied economically. These securities may also lose value due to changes in foreign currency exchange rates against the U.S. dollar and/or currencies of other countries. Issuers of these securities may be more susceptible to actions of foreign governments, such as nationalization, currency blockage or the imposition of price controls, sanctions, or punitive taxes, each of which could adversely impact the value of these securities. Securities markets in certain countries may be more volatile and/or less liquid than those in the United States. Investments outside the U.S. may also be subject to different regulatory, legal, accounting, auditing, financial reporting and recordkeeping requirements, and may be more difficult to value, than those in the U.S. In addition, the value of investments outside the U.S. may be reduced by foreign taxes, including foreign withholding taxes on interest and dividends. Further, there may be increased risks of delayed settlement of securities purchased or sold by the fund, which could impact the liquidity of the fund's portfolio. The risks of investing outside the U.S. may be heightened in connection with investments in emerging markets.

**Investing in emerging markets —** Investing in emerging markets may involve risks in addition to and greater than those generally associated with investing in the securities markets of developed countries. For instance, emerging market countries tend to have less developed political, economic and legal systems than those in developed countries. Accordingly, the governments of these countries may be less stable and more likely to intervene in the market economy, for example, by imposing capital controls, nationalizing a company or industry, placing restrictions on foreign ownership and on withdrawing sale proceeds of securities from the country, and/or imposing punitive taxes that could adversely affect the prices of securities. Information regarding issuers in emerging markets may be limited, incomplete or inaccurate, and such issuers may not be subject to regulatory, accounting, auditing, and financial reporting and recordkeeping standards comparable to those to which issuers in more developed markets are subject. The fund's rights with respect to its investments in emerging markets, if any, will generally be governed by local law, which may make it difficult or impossible for the fund to pursue legal remedies or to obtain and enforce judgments in local courts. In addition, the economies of these countries may be dependent on relatively few industries, may have limited access to capital and may be more susceptible to changes in local and global trade conditions and downturns in the world economy. Securities markets in these countries can also be relatively small and have substantially lower trading volumes. As a result, securities issued in these countries may be more volatile and less liquid, more vulnerable to market manipulation, and more difficult to value, than securities issued in countries with more developed economies and/or markets. Less certainty with respect to security valuations may lead to additional challenges and risks in calculating the fund's net asset value. Additionally, emerging markets are more likely to experience problems with the clearing and settling of trades and the holding of securities by banks, agents and depositories that are less established than those in developed countries.

**Management —** The investment adviser to the fund actively manages the fund's investments. Consequently, the fund is subject to the risk that the methods and analyses, including models, tools and data, employed by the investment adviser in this process may be flawed or incorrect and may not produce the desired results. This could cause the fund to lose value or its investment results to lag relevant benchmarks or other funds with similar objectives.

---

| | |
|:---|:---|
| Capital Group Central Corporate Bond Fund | **22** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**5. Certain investment techniques**

------

**Futures contracts** — The fund has entered into futures contracts, which provide for the future sale by one party and purchase by another party of a specified amount of a specific financial instrument for a specified price, date, time and place designated at the time the contract is made. Futures contracts are used to strategically manage the fund's interest rate sensitivity by increasing or decreasing the duration of the fund or a portion of the fund's portfolio.

Upon entering into futures contracts, and to maintain the fund's open positions in futures contracts, the fund is required to deposit with a futures broker, known as a futures commission merchant ("FCM"), in a segregated account in the name of the FCM an amount of cash, U.S. government securities or other liquid securities, known as initial margin. The margin required for a particular futures contract is set by the exchange on which the contract is traded to serve as collateral, and may be significantly modified from time to time by the exchange during the term of the contract.

On a daily basis, the fund pays or receives variation margin based on the increase or decrease in the value of the futures contracts and records variation margin on futures contracts in the statement of assets and liabilities. Futures contracts may involve a risk of loss in excess of the variation margin shown on the fund's statement of assets and liabilities. The fund records realized gains or losses at the time the futures contract is closed or expires. Net realized gains or losses and net unrealized appreciation or depreciation from futures contracts are recorded in the fund's statement of operations. The average month-end notional amount of futures contracts while held was $4,123,795,000.

**Swap contracts** — The fund has entered into swap agreements, which are two-party contracts entered into primarily by institutional investors for a specified time period. In a typical swap transaction, two parties agree to exchange the returns earned or realized from one or more underlying assets or rates of return. Swap agreements can be traded on a swap execution facility (SEF) and cleared through a central clearinghouse (cleared), traded over-the-counter (OTC) and cleared, or traded bilaterally and not cleared. Because clearing interposes a central clearinghouse as the ultimate counterparty to each participant's swap, and margin is required to be exchanged under the rules of the clearinghouse, central clearing is intended to decrease (but not eliminate) counterparty risk relative to uncleared bilateral swaps. To the extent the fund enters into bilaterally negotiated swap transactions, the fund will enter into swap agreements only with counterparties that meet certain credit standards and subject to agreed collateralized procedures. The term of a swap can be days, months or years and certain swaps may be less liquid than others.

Upon entering into a centrally cleared swap contract, the fund is required to deposit cash, U.S. government securities or other liquid securities, which is known as initial margin. Generally, the initial margin required for a particular swap is set and held as collateral by the clearinghouse on which the contract is cleared. The amount of initial margin required may be significantly modified from time to time by the clearinghouse during the term of the contract.

On a daily basis, interest accruals related to the exchange of future payments are recorded as a receivable and payable in the fund's statement of assets and liabilities for centrally cleared swaps and as unrealized appreciation or depreciation in the fund's statement of assets and liabilities for bilateral swaps. For centrally cleared swaps, the fund also pays or receives a variation margin based on the increase or decrease in the value of the swaps, including accrued interest as applicable, and records variation margin in the statement of assets and liabilities. The fund records realized gains and losses on both the net accrued interest and any gain or loss recognized at the time the swap is closed or expires. Net realized gains or losses, as well as any net unrealized appreciation or depreciation, from swaps are recorded in the fund's statement of operations.

Swap agreements can take different forms. The fund has entered into the following types of swap agreements:

**Credit default swap indices** — The fund has entered into centrally cleared credit default swap indices, including CDX and iTraxx indices (collectively referred to as "CDSI"), in order to assume exposure to a diversified portfolio of credits or to hedge against existing credit risks. A CDSI is based on a portfolio of credit default swaps with similar characteristics, such as credit default swaps on high-yield bonds. In a typical CDSI transaction, one party (the protection buyer) is obligated to pay the other party (the protection seller) a stream of periodic payments over the term of the contract. If a credit event, such as a default or restructuring, occurs with respect to any of the underlying reference obligations, the protection seller must pay the protection buyer the loss on those credits.

The fund may enter into a CDSI transaction as either protection buyer or protection seller. If the fund is a protection buyer, it would pay the counterparty a periodic stream of payments over the term of the contract and would not recover any of those payments if no credit events were to occur with respect to any of the underlying reference obligations. However, if a credit event did occur, the fund, as a protection buyer, would have the right to deliver the referenced debt obligations or a specified amount of cash, depending on the terms of the applicable agreement, and to receive the par value of such debt obligations from the counterparty protection seller.

---

| | |
|:---|:---|
| **23** | Capital Group Central Corporate Bond Fund |

---

------

As a protection seller, the fund would receive fixed payments throughout the term of the contract if no credit events were to occur with respect to any of the underlying reference obligations. If a credit event were to occur, however, the value of any deliverable obligation received by the fund, coupled with the periodic payments previously received by the fund, may be less than the full notional value that the fund, as a protection seller, pays to the counterparty protection buyer, effectively resulting in a loss of value to the fund. Furthermore, as a protection seller, the fund would effectively add leverage to its portfolio because it would have investment exposure to the notional amount of the swap transaction. The average month-end notional amount of credit default swaps while held was $540,811,000.

The following tables identify the location and fair value amounts on the fund's statement of assets and liabilities and the effect on the fund's statement of operations resulting from the fund's use of futures contracts and credit default swaps as of, or for the six months ended, November 30, 2025 (dollars in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Assets** | **Assets** | **Liabilities** | **Liabilities** |
| <br>**Contracts** | <br>**Risk type** | &nbsp;&nbsp; **Location on statement of** <br>**assets and liabilities**<br>| **Value** | &nbsp;&nbsp; **Location on statement of** <br>**assets and liabilities**<br>| **Value** |
| Futures | Interest | Unrealized appreciation\* | $3852 | Unrealized depreciation\* | $11592 |
| Swap (centrally <br> cleared)<br>| Credit | Unrealized appreciation\* |  | Unrealized depreciation\* | 196 |
|  |  |  | $3852 |  | $11788 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Net realized gain (loss)** | **Net realized gain (loss)** | **Net unrealized appreciation (depreciation)** | **Net unrealized appreciation (depreciation)** |
| <br>**Contracts** | <br>**Risk type** | **Location on statement of operations** | **Value** | **Location on statement of operations** | **Value** |
| Futures | Interest | Net realized gain (loss) on futures contracts | $(7920)<br>| &nbsp;&nbsp; Net unrealized appreciation (depreciation) <br> on futures contracts<br>| $(2364)<br>|
| Swap | Credit | Net realized gain (loss) on swap contracts | (5803)<br>| &nbsp;&nbsp; Net unrealized appreciation (depreciation) <br> on swap contracts<br>| 79 |
|  |  |  | $(13723)<br>|  | $(2285)<br>|

---

\*

Includes cumulative appreciation/depreciation on futures contracts and centrally cleared credit default swaps as reported in the applicable tables following the fund's investment portfolio. Only current day's variation margin is reported within the fund's statement of assets and liabilities.

**Collateral** — The fund receives or pledges highly liquid assets, such as cash or U.S. government securities, as collateral due to its use of futures contracts and credit default swaps. For futures contracts and centrally cleared credit default swaps, the fund pledges collateral for initial and variation margin by contract. The purpose of the collateral is to cover potential losses that could occur in the event that either party cannot meet its contractual obligation. Non-cash collateral pledged by the fund, if any, is disclosed in the fund's investment portfolio, and cash collateral pledged by the fund, if any, is held in a segregated account with the fund's custodian, which is reflected as pledged cash collateral in the fund's statement of assets and liabilities.

**6. Taxation and distributions**

------

**Federal income taxation** — The fund complies with the requirements under Subchapter M of the Internal Revenue Code applicable to regulated investment companies and intends to distribute substantially all of its net taxable income and net capital gains each year. The fund is not subject to income taxes to the extent such distributions are made. Therefore, no federal income tax provision is required.

As of and during the period ended November 30, 2025, the fund did not have a liability for any unrecognized tax benefits. The fund recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the statement of operations. During the period, the fund did not incur any significant interest or penalties.

The fund's tax returns are generally not subject to examination by federal, state and, if applicable, non-U.S. tax authorities after the expiration of each jurisdiction's statute of limitations, which is typically three years after the date of filing but can be extended in certain jurisdictions.

**Non-U.S. taxation** — Dividend and interest income are recorded net of non-U.S. taxes paid. The fund may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. These reclaims are recorded when the amount is known and there are no significant uncertainties on collectability. Gains realized by the fund on the sale of securities in certain countries, if any, may be subject to non-U.S. taxes. The fund generally records an estimated deferred tax liability based on unrealized gains to provide for potential non-U.S. taxes payable upon the sale of these securities.

---

| | |
|:---|:---|
| Capital Group Central Corporate Bond Fund | **24** |

---

------

**Distributions** — Distributions determined on a tax basis may differ from net investment income and net realized gains for financial reporting purposes. These differences are due primarily to different treatment for items such as short-term capital gains and losses; capital losses related to sales of certain securities within 30 days of purchase; cost of investments sold; net capital losses and income on certain investments. The fiscal year in which amounts are distributed may differ from the year in which the net investment income and net realized gains are recorded by the fund for financial reporting purposes.

The components of distributable earnings on a tax basis are reported as of the fund's most recent year-end. As of May 31, 2025, the components of distributable earnings on a tax basis were as follows (dollars in thousands):

---

| | |
|:---|:---|
| Undistributed ordinary income | $5420 |
| Capital loss carryforward\* | (2200979)<br>|

---

\*

The capital loss carryforward will be used to offset any capital gains realized by the fund in the current year or in subsequent years. The fund will not make distributions from capital gains while a capital loss carryforward remains.

As of November 30, 2025, the tax basis unrealized appreciation (depreciation) and cost of investments were as follows (dollars in thousands):

---

| | |
|:---|:---|
| Gross unrealized appreciation on investments | $201829 |
| Gross unrealized depreciation on investments | (173770)<br>|
| Net unrealized appreciation (depreciation) on investments | 28059 |
| Cost of investments | 11084627 |

---

Tax-basis distributions paid or accrued to shareholders from ordinary income were as follows (dollars in thousands):

---

| | | |
|:---|:---|:---|
| <br>**Share class** | **Six months ended** <br>**November 30,**<br>**2025** | **Year ended** <br>**May 31,**<br>**2025** |
| Class M | &nbsp;&nbsp; $255240 | $513755 |

---

**7. Fees and transactions with related parties**

------

CRMC, the fund's investment adviser, is the parent company of Capital Client Group, Inc. ("CCG"), the distributor of the fund's shares, and American Funds Service Company® ("AFS"), the fund's transfer agent. CRMC, CCG and AFS are considered related parties to the fund.

**Transfer agent services** — The fund has a shareholder services agreement with AFS under which the fund compensates AFS for providing transfer agent services to the fund. These services include recordkeeping and transaction processing.

**Trustees' deferred compensation** — Trustees who are unaffiliated with CRMC may elect to defer the cash payment of part or all of their compensation. These deferred amounts, which remain as liabilities of the fund, are treated as if invested in shares of the fund or other American Funds. These amounts represent general, unsecured liabilities of the fund and vary according to the total returns of the selected funds. Trustees' compensation of $33,000 in the fund's statement of operations reflects $21,000 in current fees (either paid in cash or deferred) and a net increase of $12,000 in the value of the deferred amounts.

**Affiliated officers and trustees** — Officers and certain trustees of the fund are or may be considered to be affiliated with CRMC, CCG and AFS. No affiliated officers or trustees received any compensation directly from the fund.

**Investment in CCF** — The fund holds shares of CCF, an institutional prime money market fund managed by CRMC. CCF invests in high-quality, short-term money market instruments. CCF is used as the primary investment vehicle for the fund's short-term instruments. CCF shares are only available for purchase by CRMC, its affiliates, and other funds managed by CRMC or its affiliates, and are not available to the public. CRMC does not receive an investment advisory services fee from CCF.

---

| | |
|:---|:---|
| **25** | Capital Group Central Corporate Bond Fund |

---

------

**Security transactions with related funds** — The fund may purchase investment securities from, or sell investment securities to, other funds managed by CRMC (or funds managed by certain affiliates of CRMC) under procedures adopted by the fund's board of trustees. The funds involved in such transactions are considered related by virtue of having a common investment adviser (or affiliated investment advisers), common trustees and/or common officers. When such transactions occur, each transaction is executed at the current market price of the security and no brokerage commissions or fees are paid in accordance with Rule 17a-7 of the 1940 Act. During the six months ended November 30, 2025, the fund did not engage in any such purchase or sale transactions with any related funds.

**Interfund lending** — Pursuant to an exemptive order issued by the SEC, the fund, along with other CRMC-managed funds (or funds managed by certain affiliates of CRMC), may participate in an interfund lending program. The program provides an alternate credit facility that permits the funds to lend or borrow cash for temporary purposes directly to or from one another, subject to the conditions of the exemptive order. The fund did not lend or borrow cash through the interfund lending program at any time during the six months ended November 30, 2025.

**8. Indemnifications**

------

The fund's organizational documents provide board members and officers with indemnification against certain liabilities or expenses in connection with the performance of their duties to the fund. In the normal course of business, the fund may also enter into contracts that provide general indemnifications. The fund's maximum exposure under these arrangements is unknown since it is dependent on future claims that may be made against the fund. The risk of material loss from such claims is considered remote. Insurance policies are also available to the fund's board members and officers.

**9. Capital share transactions**

------

Capital share transactions in the fund were as follows (dollars and shares in thousands):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Sales** | **Sales** | **Reinvestments of**<br> **distributions** | **Reinvestments of**<br> **distributions** | **Repurchases** | **Repurchases** | **Net increase**<br> **(decrease)** | **Net increase**<br> **(decrease)** |
| <br>**Share class** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** |
| **Six months ended November 30, 2025** | **Six months ended November 30, 2025** | **Six months ended November 30, 2025** | **Six months ended November 30, 2025** | **Six months ended November 30, 2025** | **Six months ended November 30, 2025** | **Six months ended November 30, 2025** | **Six months ended November 30, 2025** | **Six months ended November 30, 2025** |
| Class M | $203930 | 24217 | &nbsp;&nbsp;&nbsp; $255240 | 30068 | &nbsp;&nbsp;&nbsp; $(271803)<br>| (32730)<br>| &nbsp;&nbsp;&nbsp; $187367 | 21555 |
| **Year ended May 31, 2025** | **Year ended May 31, 2025** | **Year ended May 31, 2025** | **Year ended May 31, 2025** | **Year ended May 31, 2025** | **Year ended May 31, 2025** | **Year ended May 31, 2025** | **Year ended May 31, 2025** | **Year ended May 31, 2025** |
| Class M | $379219 | 45239 | &nbsp;&nbsp;&nbsp; $513798 | 61122 | &nbsp;&nbsp;&nbsp; $(1446913)<br>| (174317)<br>| &nbsp;&nbsp;&nbsp; $(553896)<br>| (67956)<br>|

---

**10. Investment transactions**

------

The fund engaged in purchases and sales of investment securities, excluding short-term securities and U.S. government obligations,

if any, of $4,447,946,000 and $4,716,696,000, respectively, during the six months ended November 30, 2025.

**11. Ownership concentration**

------

At November 30, 2025, two shareholders held more than 10% of the fund's outstanding shares. The two shareholders were American Balanced Fund and Capital Income Builder, with aggregate ownership of the fund's outstanding shares of 61% and 25%, respectively. CRMC is the investment adviser to the two American Funds.

---

| | |
|:---|:---|
| Capital Group Central Corporate Bond Fund | **26** |

---

------

Financial highlights

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Income (loss) from investment operations**<sup>1</sup> | **Income (loss) from investment operations**<sup>1</sup> | **Income (loss) from investment operations**<sup>1</sup> | **Dividends and distributions** | **Dividends and distributions** | **Dividends and distributions** | | | | | |
| <br>**Year ended**  | <br>**Net asset** <br>**value,** <br>**beginning** <br>**of year**<br>| **Net** <br>**investment** <br>**income** <br>**(loss)**<br>| **Net gains** <br>**(losses) on** <br>**securities** <br>**(both** <br>**realized and** <br>**unrealized)**<br>| **Total from** <br>**investment** <br>**operations**<br>| **Dividends** <br>**(from net** <br>**investment** <br>**income)**<br>| **Distributions** <br>**(from capital** <br>**gains)**<br>| **Total** <br>**dividends** <br>**and** <br>**distributions**<br>| <br>**Net asset** <br>**value, end** <br>**of year**<br>| <br>**Total return** | <br>**Net assets,** <br>**end of year** <br>**(in millions)** <br>| <br>**Ratio of** <br>**expenses to** <br>**average** <br>**net assets**<sup>2</sup> <br>| <br>**Ratio of** <br>**net income** <br>**(loss) to** <br>**average** <br>**net assets**<br>|
| **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  | **Class M:**  |
| 11/30/2025<sup>3,4</sup> <br>| $8.32 | &nbsp;&nbsp; $.21 | &nbsp;&nbsp; $.24 | &nbsp;&nbsp; $.45 | &nbsp;&nbsp; $(.20)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $(.20)<br>| &nbsp;&nbsp; $8.57 | 5.47 %<sup>5</sup><br>| &nbsp;&nbsp; $11094 | &nbsp;&nbsp; — %<sup>6,7</sup><br>| 4.84 %<sup>7</sup><br>|
| 5/31/2025 | 8.24 | &nbsp;&nbsp; .40 | &nbsp;&nbsp; .07 | &nbsp;&nbsp; .47 | &nbsp;&nbsp; (.39)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (.39)<br>| 8.32 | 5.77 | &nbsp;&nbsp; 10593 | &nbsp;&nbsp; — <br><sup>6</sup><br>| 4.73 |
| 5/31/2024 | 8.29 | &nbsp;&nbsp; .36 | &nbsp;&nbsp; (.06)<br>| &nbsp;&nbsp; .30 | &nbsp;&nbsp; (.35)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (.35)<br>| 8.24 | 3.74 | &nbsp;&nbsp; 11049 | &nbsp;&nbsp; — <br><sup>6</sup><br>| 4.42 |
| 5/31/2023 | 8.69 | &nbsp;&nbsp; .29 | &nbsp;&nbsp; (.40)<br>| &nbsp;&nbsp; (.11)<br>| &nbsp;&nbsp; (.29)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (.29)<br>| 8.29 | &nbsp;&nbsp; (1.23)<br>| &nbsp;&nbsp; 11514 | &nbsp;&nbsp; — <br><sup>6</sup><br>| 3.54 |
| 5/31/2022 | 10.00 | &nbsp;&nbsp; .25 | &nbsp;&nbsp; (1.23)<br>| &nbsp;&nbsp; (.98)<br>| &nbsp;&nbsp; (.24)<br>| &nbsp;&nbsp; (.09)<br>| &nbsp;&nbsp; (.33)<br>| 8.69 | &nbsp;&nbsp; (10.08)<br>| &nbsp;&nbsp; 14294 | &nbsp;&nbsp; — <br><sup>6</sup><br>| 2.57 |
| 5/31/2021<sup>3,8</sup> <br>| 10.00 | &nbsp;&nbsp; — <br><sup>9</sup><br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — <br><sup>9</sup><br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | 10.00 | &nbsp;&nbsp; .00 | &nbsp;&nbsp; — <br><sup>10</sup><br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — <br><sup>5,6</sup><br>|

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Six months** <br>**ended** <br>**November 30,** <br>**2025**<sup>3,4,5</sup>  | **Year ended May 31,** | **Year ended May 31,** | **Year ended May 31,** | **Year ended May 31,** |
|  | **Six months** <br>**ended** <br>**November 30,** <br>**2025**<sup>3,4,5</sup>  | **2025** | **2024** | **2023** | **2022** |
| Portfolio turnover rate for all share classes<sup>11</sup> | &nbsp;&nbsp; 105<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 205<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 151<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 132<br> %<br>| &nbsp;&nbsp;&nbsp;&nbsp; 94<br> %<br>&nbsp;&nbsp;&nbsp;&nbsp; —<br> %<sup>12</sup><br>|

---

<sup>1</sup> Based on average shares outstanding.

<sup>2</sup> Ratios do not include expenses of any Central Funds. The fund indirectly bears its proportionate share of the expenses of any Central Funds.

<sup>3</sup> Based on operations for a period that is less than a full year.

<sup>4</sup> Unaudited.

<sup>5</sup> Not annualized.

<sup>6</sup> Amount less than .01%.

<sup>7</sup> Annualized.

<sup>8</sup> Class M shares began investment operations on April 23, 2021.

<sup>9</sup> Amount less than $.01.

<sup>10</sup> Amount less than $1 million.

<sup>11</sup> Rates do not include the fund's portfolio activity with respect to any Central Funds.

<sup>12</sup> There was no turnover.

Refer to the notes to financial statements.

---

| | |
|:---|:---|
| **27** | Capital Group Central Corporate Bond Fund |

---

------

Changes in and disagreements with accountants

------

None

Matters submitted for shareholder vote

------

**Results of special meeting of shareholders**

held November 25, 2025

Shares outstanding (all classes) on August 28, 2025 (record date):

1,266,654,545

Total shares voting on November 25, 2025:

1,266,654,545 (100.0% of shares outstanding)

The proposal: To elect board members

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Board member** | **Votes for** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Percent** <br> **of shares** <br> **voting for**<br>| **Votes withheld** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Percent** <br> **of shares** <br> **withheld**<br>|
| Gina F. Adams | 1266654545 | 100.0% | 0 | 0.0% |
| Pramod Atluri | 1266654545 | 100.0% | 0 | 0.0% |
| Francisco G. Cigarroa | 1266654545 | 100.0% | 0 | 0.0% |
| Nariman Farvardin | 1266654545 | 100.0% | 0 | 0.0% |
| Jennifer C. Feikin | 1266654545 | 100.0% | 0 | 0.0% |
| Leslie Stone Heisz | 1266654545 | 100.0% | 0 | 0.0% |
| Merit E. Janow | 1266654545 | 100.0% | 0 | 0.0% |
| Martin E. Koehler | 1266654545 | 100.0% | 0 | 0.0% |
| Benjamin R. Miller | 1266654545 | 100.0% | 0 | 0.0% |
| Josette Sheeran | 1266654545 | 100.0% | 0 | 0.0% |
| Margaret Spellings | 1266654545 | 100.0% | 0 | 0.0% |
| Alexandra Trower | 1266654545 | 100.0% | 0 | 0.0% |
| Paul S. Williams | 1266654545 | 100.0% | 0 | 0.0% |
| Courtney K. Wolf | 1266654545 | 100.0% | 0 | 0.0% |

---

Remuneration paid to directors, officers and others

------

Refer to the trustees' deferred compensation disclosure in the notes to financial statements.

Approval of Investment Advisory and Service Agreement

------

Not applicable for the current reporting period due to the timing of the board's approval of this agreement.

---

| | |
|:---|:---|
| Capital Group Central Corporate Bond Fund | **28** |

---

------

#### ITEM 8 - Changes in and Disagreements with Accountants for Open-End Management Investment Companies
None

------

#### ITEM 9 - Proxy Disclosures for Open-End Management Investment Companies
The information is included as part of the material filed under Item 7 of this Form under Matters submitted for shareholder vote.

------

#### ITEM 10 - Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies
The information is included as part of the material filed under Item 7 of this Form within the trustees' deferred compensation disclosure in the notes to financial statements.

------

#### ITEM 11 - Statement Regarding Basis for Approval of Investment Advisory Contract
Not applicable for the current reporting period due to the timing of the board's approval of this agreement.

------

#### ITEM 12 - Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies
Not applicable to this Registrant, insofar as the Registrant is not a closed-end management investment company.

------

#### ITEM 13 - Portfolio Managers of Closed-End Management Investment Companies
Not applicable to this Registrant, insofar as the Registrant is not a closed-end management investment company.

------

#### ITEM 14 - Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers
Not applicable to this Registrant, insofar as the Registrant is not a closed-end management investment company.

------

#### ITEM 15 - Submission of Matters to a Vote of Security Holders
There have been no material changes to the procedures by which shareholders may recommend nominees to the Registrant's board of trustees since the Registrant last submitted a proxy statement to its shareholders. The procedures are as follows. The Registrant has a nominating and governance committee comprised solely of persons who are not considered ''interested persons'' of the Registrant within the meaning of the Investment Company Act of 1940, as amended. The committee periodically reviews such issues as the board's composition, responsibilities, committees, compensation and other relevant issues, and recommends any appropriate changes to the full board of trustees. The committee also coordinates annual self-assessments of the board and evaluates, selects and nominates independent trustee candidates to the full board of trustees. While the committee normally is able to identify from its own and other resources an ample number of qualified candidates, it will consider shareholder suggestions of persons to be considered as nominees to fill future vacancies on the board. Such suggestions must be sent in writing to the nominating and governance committee of the Registrant, c/o the Registrant's Secretary, and must be accompanied by complete biographical and occupational data on the prospective nominee, along with a written consent of the prospective nominee for consideration of his or her name by the nominating and governance committee.

------

#### ITEM 16 - Controls and Procedures
(a) The Registrant's Principal Executive Officer and Principal Financial Officer have concluded, based on their evaluation of the Registrant's disclosure controls and procedures (as such term is defined in Rule 30a-3 under the Investment Company Act of 1940) as of a date within 90 days of the filing date of this report, that such controls and procedures are adequate and reasonably designed to achieve the purposes described in paragraph (c) of such rule.

(b) There were no changes in the Registrant's internal controls over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.

------

#### ITEM 17 - Disclosure of Securities Lending Activities for Closed-End Management Investment Companies
Not applicable to this Registrant, insofar as the Registrant is not a closed-end management investment company.

------

#### ITEM 18 - Recovery of Erroneously Awarded Compensation
None

------

#### ITEM 19 - Exhibits
(a)(1) Not applicable for filing of semi-annual reports to shareholders.

(a)(2) The certifications required by Rule 30a-2 of the Investment Company Act of 1940 and Sections [302](cert302.htm) and [906](cert906.htm) of the Sarbanes-Oxley Act of 2002 are attached as exhibits hereto.

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

**Capital Group Central Fund Series II**

By /s/ Kristine M. Nishiyama

Kristine M. Nishiyama,

Principal Executive Officer

Date: January 30, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

By /s/ Kristine M. Nishiyama

Kristine M. Nishiyama,

Principal Executive Officer

Date: January 30, 2026

By /s/ Becky L. Park

Becky L. Park, Treasurer and

Principal Financial Officer

Date: January 30, 2026

------

## Exhibit 99.906

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

KRISTINE M. NISHIYAMA, Principal Executive Officer, and BECKY L. PARK, Treasurer and Principal Financial Officer of Capital Group Central Fund Series II (the "Registrant"), each certify to the best of her or his knowledge that:

1. The Registrant's periodic report on Form N-CSR for the period ended November 30, 2025 (the "Form N-CSR") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Principal Executive Officer

**Capital Group Central Fund Series II**

<u>/s/ Kristine M. Nishiyama</u>

Kristine M. Nishiyama, Principal Executive Officer

Date: January 30, 2026

Principal Financial Officer

**Capital Group Central Fund Series II**

<u>/s/ Becky L. Park</u>

Becky L. Park, Treasurer and Principal Financial Officer

Date: January 30, 2026

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to **Capital Group Central Fund Series II** and will be retained by **Capital Group Central Fund Series II** and furnished to the Securities and Exchange Commission (the "Commission") or its staff upon request.

This certification is being furnished to the Commission solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Form N-CSR filed with the Commission.

------

## Ex-99.Cert

**CERTIFICATION**

**I, Kristine M. Nishiyama, certify that:**

1. I have reviewed this report on Form N-CSR of **Capital Group Central Fund Series II**;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal controls over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of trustees (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: January 30, 2026

<u>/s/ Kristine M. Nishiyama</u> Kristine M. Nishiyama, Principal Executive Officer Capital Group Central Fund Series II

**CERTIFICATION**

I, **Becky L. Park**, certify that:

1. I have reviewed this report on Form N-CSR of **Capital Group Central Fund Series II**;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal controls over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of trustees (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: January 30, 2026

<u>/s/ Becky L. Park</u> Becky L. Park,

Treasurer and Principal Financial Officer

Capital Group Central Fund Series II

------